GLP-1 Market
LLY $1183.46 ▲ +0.1% NVO $38.80 ▲ +0.5% PFE $28.67 ▲ +0.9% VKTX $35.56 ▼ -3.2% KLRA $11.21 ▼ -6.4% GPCR $35.93 ▼ -0.2% RHHBY $54.41 ▼ -0.7%
Market data delayed up to 20 min · Source: Twelve Data

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Ranibizumab

Company
Incepta Pharmaceuticals Ltd
Mechanism
Mechanism not yet reported
Route
Injectable
Recruiting trials
17 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

17 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 26, 2026

Find a Clinical Trial Near Me

See recruiting studies for Ranibizumab and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT02669953

    Aflibercept in Recurrent or Persistent CNV

    Medical University of Vienna 80 participants Est. completion 2025-12 1 site
    Other conditions: Age Related Macular Degeneration, Intravitreal Injections, Diabetic Macular Edema
    View official trial listing →
  • Recruiting NCT NCT04337515

    A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant

    Not yet reported Christopher Dvorak 90 participants Est. completion 2035-01-01 1 site Stand-alone
    Other conditions: Graft Vs Host Disease, Graft-versus-host-disease
    View official trial listing →
  • Recruiting NCT NCT04413994

    Exclusive Human-milk in Preterm NEOnates and Early VASCular Aging Risk Factors (NEOVASC)

    Not yet reported Prolacta Bioscience 200 participants Est. completion 2028-06-01 1 site
    Other conditions: Prematurity, Vascular Aging
    View official trial listing →
  • Recruiting NCT NCT05691244

    Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke

    Not yet reported Pharmazz, Inc. 514 participants Est. completion 2027-12 54 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06488274

    Evolution of Functional Gastrointestinal Disorders in Infants Fed With a New Infant Formula

    Not yet reported United Pharmaceuticals 139 participants Est. completion 2026-04 4 sites Stand-alone
    Other conditions: Functional Gastrointestinal Disorders
    View official trial listing →
  • Recruiting NCT NCT06697288

    Evaluation of Efficacy of Anthelios Sunscreen on Face Versus Usual Routine on Signs of Aging

    Not yet reported Cosmetique Active International 260 participants Est. completion 2025-08 1 site Stand-alone
    Other conditions: Aging
    View official trial listing →
  • Recruiting NCT NCT06712680

    A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes

    Not yet reported, Not yet reported Sichuan Huiyu Pharmaceutical Co., Ltd 115 participants Est. completion 2028-04-10 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT06781619

    Effect of Plant Based High Energy High Protein Oral Nutritional Supplement on Nutritional Intake in Patients With or at Risk of Disease Related Malnutrition.

    Not yet reported Nutricia Research 80 participants Est. completion 2027-07 2 sites Stand-alone
    Other conditions: Disease Related Malnutrition
    View official trial listing →
  • Recruiting NCT NCT06985706

    Anti-vascular Endothelial Growth Factor (Anti-VEGF) Monotherapy vs Anti-VEGF Followed by Subthreshold Micropulse Laser for Treating Severe Diabetic Macular Oedema When the Central Retina Goes <400 Microns

    Not yet reported Belfast Health and Social Care Trust 264 participants Est. completion 2028-11-30 22 sites
    Other conditions: Severe Diabetic Macular Oedema
    View official trial listing →
  • Recruiting NCT NCT07014007

    Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks

    Not yet reported Pierre Fabre Dermo Cosmetique 105 participants Est. completion 2026-11 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Recruiting NCT NCT07249216

    Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting

    Not yet reported Singapore National Eye Centre 117 participants Est. completion 2029-07 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Recruiting NCT NCT07520045

    Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

    Not yet reported Osijek University Hospital 100 participants Est. completion 2027-06-01 1 site
    Other conditions: Diabetic Retinopathy (DR), Diabetic Macular Edema (DME)
    View official trial listing →
  • Recruiting NCT NCT07620041

    Phase I Study of QLC5508 in Advanced Solid Tumors: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

    Not yet reported Qilu Pharmaceutical Co., Ltd. 48 participants Est. completion 2027-02-05 1 site Stand-alone
    Other conditions: Refractory or Relapsed Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT07632274

    A Study to Evaluate Ibuprofen (IBU) 62.5 mg and Acetaminophen (APAP) 125 mg/5 ml in an Oral Liquid Suspension Fixed-Dose Combination Product in Children Aged 6 to 11 Years

    Not yet reported HALEON 12 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Recruiting NCT NCT07667088

    Oil Pulling Whitening Mouthwash

    Not yet reported The University of Texas Health Science Center at San Antonio 120 participants Est. completion 2026-08-31 1 site Stand-alone
    Other conditions: Healthy Adult Participants, Tooth Stain
    View official trial listing →
  • Recruiting NCT NCT07695207

    Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy

    Not yet reported SANGMYUNG innovation 266 participants Est. completion 2028-07 1 site Stand-alone
    Other conditions: Neovascular (Wet) Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
    View official trial listing →
  • Recruiting NCT NCT07749092

    Kimchi Powder on Gut Health

    Not yet reported Pusan National University Yangsan Hospital 100 participants Est. completion 2027-12-31 1 site
    Other conditions: Irritable Bowel Syndrome - Diarrhoea
    View official trial listing →
  • Completed NCT NCT00056823

    Intravitreal Injections of rhuFab V2 in Combination With Visudyne in Subjects With Age Related Macular Degeneration (AMD)

    Not yet reported, Not yet reported Genentech, Inc. 168 participants Est. completion 2005-12
    Other conditions: Age-Related Maculopathy
    View official trial listing →
  • Completed NCT NCT00056836

    A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration

    Not yet reported Genentech, Inc. 720 participants Est. completion 2005-12
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00304954

    Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular Degeneration

    Not yet reported National Eye Institute (NEI) 13 participants Est. completion 2010-01 1 site
    Other conditions: Age-Related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT00331864

    SUSTAIN - Study of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-Related Macular Degeneration

    Not yet reported Novartis 531 participants Est. completion 2008-04 1 site Stand-alone
    Other conditions: Age Related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT00353028

    Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents

    Not yet reported Solvay Pharmaceuticals 90 participants Est. completion 2009-07 25 sites Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT00378196

    Ranibizumab in Idiopathic Parafoveal Telangiectasia (RIPT) Trial

    Not yet reported Johns Hopkins University 10 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Telangiectasia
    View official trial listing →
  • Completed NCT NCT00403039

    Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema

    Not yet reported Vitreous -Retina- Macula Consultants of New York 41 participants Est. completion 2011-12 1 site
    Other conditions: Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT00406471

    Rubeosis Anti-VEGF (RAVE) Trial for Ischemic Central Retinal Vein Occlusion

    Not yet reported Greater Houston Retina Research 20 participants Est. completion 2011-01 1 site
    Other conditions: Ischemic Central Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT00407355

    Ranibizumab (Lucentis) for Macular Edema Secondary to Vein Occlusions

    Not yet reported, Not yet reported Peter A Campochiaro, MD 40 participants Est. completion 2013-02 1 site
    Other conditions: Macular Edema, Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT00413829

    Immediate Effects of Lucentis® in Conjunction With Photodynamic Therapy With Visudyne® in Exudative AMD(IECOMB)

    Not yet reported Insel Gruppe AG, University Hospital Bern 20 participants Est. completion 2008-03 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00429962

    Study Comparing Ranibizumab Monotherapy With Combined Verteporfin Therapy in Subfoveal CNV

    Not yet reported University Hospital, Basel, Switzerland 40 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Choroidal Neovascularization, Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00436553

    Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

    Not yet reported Novartis 321 participants Est. completion 2009-10 43 sites Stand-alone
    Other conditions: Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Status unknown NCT NCT00454389

    A Study of Strontium90 Beta Radiation With Lucentis to Treat Age-Related Macular Degeneration

    Not yet reported NeoVista 494 participants Est. completion 2012-08 32 sites Stand-alone
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00456495

    Effect of Ranibizumab on Malignant Conjunctival Neoplasia

    Not yet reported The New York Eye Cancer Center 5 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Conjunctival Neoplasms
    View official trial listing →
  • Completed NCT NCT00457145

    Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

    Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2007-10-24 1 site
    Other conditions: Telangiectasia
    View official trial listing →
  • Completed NCT NCT00464581

    Lucentis for Treatment of Macular Edema

    Retina Institute of Hawaii 30 participants Est. completion 2009-12 1 site
    Other conditions: Cystoid Macular Edema
    View official trial listing →
  • Completed NCT NCT00467935

    Scotoma Reduction in AMD Patients Treated With Ranibizumab

    Not yet reported, Not yet reported Retina Research Foundation 20 participants Est. completion 2007-11 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00470977

    Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

    Not yet reported, Not yet reported Manhattan Eye, Ear & Throat Hospital 18 participants Est. completion 2010-12 2 sites Stand-alone
    Other conditions: Coats' Disease, Idiopathic Retinal Telangiectasia, Retinal Angiomatous Proliferation, Polypoidal Choroidal Vasculopathy, Pseudoxanthoma Elasticum, Pathological Myopia, Multi-focal Choroiditis, Rubeosis Iridis, Von Hippel Lindau Disease, BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder)
    View official trial listing →
  • Completed NCT NCT00473330

    A Study of Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

    Not yet reported Genentech, Inc. 377 participants Est. completion 2012-11 Stand-alone
    Other conditions: Diabetes Mellitus, Macular Edema
    View official trial listing →
  • Completed NCT NCT00473642

    Reduced Fluence Photodynamic Therapy (PDT) With Visudyne in Combination With Lucentis for Age-Related Macular Degeneration

    Not yet reported Oklahoma State University Center for Health Sciences 31 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Age-Related Maculopathy, Choroidal Neovascularization
    View official trial listing →
  • Terminated NCT NCT00474695

    Study Evaluating Genotypes Using Lucentis

    University of Utah 65 participants Est. completion 2009-12 3 sites
    Other conditions: Age-Related Maculopathy
    View official trial listing →
  • Completed NCT NCT00492284

    Reduced Fluence Visudyne-Anti-VEGF-Dexamethasone In Combination for AMD Lesions (RADICAL)

    Not yet reported QLT Inc. 162 participants Est. completion 2010-05 26 sites Stand-alone
    Other conditions: Choroidal Neovascularization, Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00498355

    Lucentis for Inflammatory Macular Edema Trial

    Not yet reported, Not yet reported University of California, San Francisco 7 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Uveitis, Cytoid Macular Edema
    View official trial listing →
  • Terminated NCT NCT00499590

    Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

    Not yet reported OPKO Health, Inc. 338 participants Est. completion 2009-05 60 sites Stand-alone
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00504400

    Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

    Not yet reported University Hospital, Bonn 10 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Type 2 Idiopathic Macular Telangiectasia
    View official trial listing →
  • Completed NCT NCT00517010

    Pilot Study of Lucentis Combined With Proton Beam Irradiation in Treating Wet Age-related Macular Degeneration

    Not yet reported University of California, Davis 6 participants Est. completion 2010-06 Stand-alone
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Withdrawn NCT NCT00538538

    Subretinal Lucentis for Hemorrhagic Age-related Macular Degeneration (AMD)

    Not yet reported Corewell Health East Est. completion 2008-10 1 site
    Other conditions: Retinal Hemorrhage, Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT00540930

    Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy

    Not yet reported Shields, Shields and Associates 400 participants Est. completion 2009-04 1 site
    Other conditions: Uveal Melanoma, Radiation Retinopathy, Radiation Maculopathy
    View official trial listing →
  • Completed NCT NCT00569140

    A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration

    Not yet reported Ophthotech Corporation 18 participants Est. completion 2008-12 1 site
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00570193

    Photodynamic and Pharmacologic Treatment of CNV

    Not yet reported, Not yet reported Mid-Atlantic Retina Consultations, Inc. 41 participants Est. completion 2011-06 Stand-alone
    Other conditions: Choroidal Neovascularization, Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00570726

    Treatment of Failing Blebs With Ranibizumab

    Not yet reported The New York Eye & Ear Infirmary 6 participants Est. completion 2007-11 1 site
    Other conditions: Glaucoma, Open-Angle, Failing Bleb Following Trabeculectomy
    View official trial listing →
  • Completed NCT NCT00574093

    Efficacy and Safety Study of Lucentis (Ranibizumab) and Visudyne (Verteporfin) Combination Therapy in Neovascular AMD

    Not yet reported Fondazione G.B. Bietti, IRCCS 15 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Neovascular Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00603681

    Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation

    Not yet reported Orion Corporation, Orion Pharma 67 participants Est. completion 2008-07 10 sites Stand-alone
    Other conditions: Constipation
    View official trial listing →
  • Completed NCT NCT00636480

    Preoperative Skin Preparation Evaluation

    Not yet reported C. R. Bard 60 participants Est. completion 2008-03 1 site
    Other conditions: Topical Antisepsis
    View official trial listing →
  • Completed NCT NCT00637377

    Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

    Not yet reported Bayer 1240 participants Est. completion 2011-08 189 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00656903

    High Speed Indocyanine Green Angiography Findings in Ranibizumab Treatment for Wet Age-related Macular Degeneration

    National Eye Institute (NEI) 75 participants Est. completion 2014-08-19 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00657202

    Ranibizumab for Neurofibromas Associated With Neurofibromatosis 1

    Not yet reported Massachusetts General Hospital 11 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Neurofibromatosis Type 1, Cutaneous Neurofibromas
    View official trial listing →
  • Completed NCT NCT00680498

    Combination Lucentis and Ocular Photodynamic Therapy With Visudyne, With Evaluation-based Retreatment

    Not yet reported Illinois Retina Associates 10 participants Est. completion 2009-10 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00685854

    Ranibizumab Injections to Treat Macular Telangiectasia Without New Blood Vessel Growth

    Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2011-03-24 1 site
    Other conditions: Macular Telangiectasia
    View official trial listing →
  • Terminated NCT NCT00709657

    The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion

    Not yet reported Medical University of Vienna 8 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Macular Degeneration, Regional Blood Flow, Vascular Endothelial Growth Factor
    View official trial listing →
  • Completed NCT NCT00716105

    Effect of the Level of Dietary Protein on Infant Growth

    Not yet reported Société des Produits Nestlé (SPN) 405 participants Est. completion 2015-02 2 sites Stand-alone
    Other conditions: Infant Nutrition
    View official trial listing →
  • Withdrawn NCT NCT00726466

    Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration

    Not yet reported Vitreous -Retina- Macula Consultants of New York 1 site Stand-alone
    Other conditions: Age Related Macular Degeneration, AMD, CNV
    View official trial listing →
  • Withdrawn NCT NCT00727038

    Lucentis for New Onset Neovascular Glaucoma

    Not yet reported, Not yet reported University of Illinois at Chicago Est. completion 2009-05-15 Stand-alone
    Other conditions: Glaucoma, New Onset Glaucoma, Neovascular Glaucoma, New Onset Neovascular Glaucoma
    View official trial listing →
  • Completed NCT NCT00750399

    Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma

    Not yet reported The New York Eye Cancer Center 10 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Radiation Retinopathy, Choroidal Melanoma
    View official trial listing →
  • Completed NCT NCT00765921

    Ranibizumab in Combination With Proton Beam Irradiation for Choroidal Melanoma

    Not yet reported Massachusetts Eye and Ear Infirmary 40 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Choroidal Melanoma
    View official trial listing →
  • Completed NCT NCT00802958

    Randomized Study to Compare the Bioavailability of Two Halobetasol Propionate 0.05% Topical Ointments

    Padagis LLC 76 participants Est. completion 2003-08
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00803439

    Randomized Study to Compare the Bioavailability of Two Clobetasol Propionate 0.05% Topical Foams

    Padagis LLC 80 participants Est. completion 2005-04
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00803738

    Safety and Equivalence of a Terconazole Vaginal Suppository (Test Product) Compared to the Reference Terconazole Vaginal Suppository in the Treatment of Vulvovaginal Candidiasis

    Not yet reported Padagis LLC 572 participants Est. completion 2003-12 Stand-alone
    Other conditions: Vulvovaginal Candidiasis
    View official trial listing →
  • Completed NCT NCT00804193

    Safety and Equivalence of a Generic Ciclopirox Olamine Topical Suspension Compared to the Reference Ciclopirox Topical Suspension 0.77% for the Treatment of Tinea Pedis

    Not yet reported Padagis LLC 553 participants Est. completion 2005-04 Stand-alone
    Other conditions: Tinea Pedis
    View official trial listing →
  • Completed NCT NCT00804401

    Bioequivalence Study Between Two Oral Formulations of Naproxen 500 mg Tablets Under Fasting Conditions

    Not yet reported Perrigo Company 34 participants
    Other conditions: Bioequivalency
    View official trial listing →
  • Completed NCT NCT00804440

    Bioequivalence Study Between Two Oral Formulations of Ibuprofen 800 mg Tablets Under Fasting Conditions

    Not yet reported Perrigo Company 30 participants
    Other conditions: Bioequivalency
    View official trial listing →
  • Completed NCT NCT00804934

    Investigates Improvement in Vision Following Switching From Avastin and Macugen Over to Lucentis

    Retina Institute of Hawaii 100 participants Est. completion 2009-01 1 site
    Other conditions: Wet AMD
    View official trial listing →
  • Status unknown NCT NCT00809419

    A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy

    Not yet reported, Not yet reported NeoVista 32 participants Est. completion 2012-11 5 sites Stand-alone
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT00811200

    Treatment Of Radiation Retinopathy Trial

    Not yet reported, Not yet reported Leiden University Medical Center 220 participants
    Other conditions: Uveal Melanoma
    View official trial listing →
  • Completed NCT NCT00826371

    Evaluation of Safety and Efficacy of Once Monthly Ranibizumab Injections in Chinese Patients With Wet Age Related Macular Degeneration (AMD) Patients

    Not yet reported Novartis Pharmaceuticals 114 participants 6 sites Stand-alone
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00835406

    Alendronate Sodium 70 mg Tablet Versus Fosamax® Under Fasting Conditions.

    Not yet reported Teva Pharmaceuticals USA 140 participants Est. completion 2000-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT00846625

    Study of Uveitic Macular Edema Treated With Ranibizumab or Steroids

    Not yet reported University of Utah Est. completion 2011-08 1 site Stand-alone
    Other conditions: Macular Edema, Uveitis
    View official trial listing →
  • Terminated NCT NCT00857259

    The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

    Not yet reported Novartis Pharmaceuticals 16 participants 12 sites
    Other conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration, Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00859196

    Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries

    Not yet reported Bayer 15 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Wound Healing, Cell Proliferation, Gene Expression
    View official trial listing →
  • Completed NCT NCT00872729

    Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics of RP103 Compared to Cystagon® in Patients With Cystinosis

    Not yet reported, Not yet reported Amgen 9 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Cystinosis
    View official trial listing →
  • Status unknown NCT NCT00885794

    Microperimetry and Optical Coherence Tomography (OCT) With Lucentis for Diabetic Macular Edema (DME)

    Not yet reported, Not yet reported The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery 40 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT00896779

    Lucentis in Advanced Macular Degeneration

    Not yet reported Steven R. Sanislo 20 participants Est. completion 2013-09 2 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00901186

    Efficacy and Safety of Ranibizumab (Intravitreal Injections) Versus Laser Treatment in Patients With Visual Impairment Due to Diabetic Macular Edema

    Not yet reported Novartis Pharmaceuticals 83 participants Est. completion 2012-08 17 sites
    Other conditions: Diabetic Macular Edema, Visual Impairment
    View official trial listing →
  • Withdrawn NCT NCT00930189

    Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization

    Not yet reported, Not yet reported Asociación para Evitar la Ceguera en México Est. completion 2006-09 1 site
    Other conditions: Subfoveal Choroidal Neovascularization
    View official trial listing →
  • Status unknown NCT NCT00955630

    Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome

    Not yet reported, Not yet reported Retina Associates of Kentucky 20 participants 1 site
    Other conditions: Ocular Histoplasmosis Syndrome
    View official trial listing →
  • Terminated NCT NCT00991510

    Comparative Bioavailability of Myfenax® and CellCept® in Kidney Transplant Patients

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 43 participants Est. completion 2010-10 Stand-alone
    Other conditions: Stable Renal Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT00993525

    Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)

    Not yet reported, Not yet reported University of Sao Paulo 22 participants Est. completion 2010-03 Stand-alone
    Other conditions: Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT00996437

    Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N)

    Not yet reported, Not yet reported Jaeb Center for Health Research 261 participants Est. completion 2013-01 67 sites
    Other conditions: Vitreous Hemorrhage, Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT01006538

    Macular EpiRetinal Brachytherapy Versus Lucentis® Only Treatment (MERLOT)

    Not yet reported King's College Hospital NHS Trust 363 participants Est. completion 2016-12 24 sites Stand-alone
    Other conditions: Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT01011374

    Impact of Lucentis on Psychological Morbidity in Patients With Retinal Vein Occlusion

    Not yet reported Retina Associates of Cleveland, Inc 45 participants Est. completion 2013-11 1 site
    Other conditions: Venous Retinal Branch Occlusion, Central Retinal Vein Occlusion, Retinal Vein Occlusion, Depression
    View official trial listing →
  • Completed NCT NCT01016782

    Study of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea

    Not yet reported Fougera Pharmaceuticals Inc. 867 participants Est. completion 2009-07 Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT01027481

    Ranibizumab in Patients With Branch Retinal Vein Occlusion

    Not yet reported Medical University of Vienna 30 participants Est. completion 2009-12 1 site
    Other conditions: Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01030770

    Preoperative Intravitreal Ranibizumab for Persistent Diabetic Vitreous Haemorrhage:

    Not yet reported, Not yet reported King's College Hospital NHS Trust 25 participants Est. completion 2016-05 2 sites Stand-alone
    Other conditions: Diabetes Complications
    View official trial listing →
  • Completed NCT NCT01036243

    Digestive Tolerance of Slightly Hydrolyzed Starter Infant Formula With Probiotics

    Not yet reported Société des Produits Nestlé (SPN) 480 participants Est. completion 2012-04 1 site
    Other conditions: Infant Nutrition
    View official trial listing →
  • Completed NCT NCT01037348

    Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen

    Not yet reported Novartis 65 participants Est. completion 2012-05 12 sites Stand-alone
    Other conditions: Choroidal Neovascularisation
    View official trial listing →
  • Completed NCT NCT01046253

    Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study

    Not yet reported Teva Pharmaceuticals USA 50 participants Est. completion 2004-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01080417

    Bioequivalence Study of Mycophenolate Mofetil 250 mg Capsule Under Fed Condition

    Not yet reported Panacea Biotec Ltd 84 participants Est. completion 2008-07 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01080586

    Bioequivalence Study of Cyclosporine 100mg Capsule Under Fed Condition

    Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01102946

    Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

    Not yet reported University of Sao Paulo 40 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Diabetic Retinopathy, Retinal Neovascularization
    View official trial listing →
  • Completed NCT NCT01112085

    MIcrodoses of raNIbizumab in Diabetic MAcular Edema (MINIMA-2)

    Not yet reported Especialistas en Retina Medica y Quirurgica Grupo de Investigacion 72 participants Est. completion 2014-06 6 sites Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01124175

    Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 80 participants Est. completion 2003-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01131585

    Safety and Efficacy of Ranibizumab in Diabetic Macular Edema

    Not yet reported Novartis Pharmaceuticals 128 participants Est. completion 2011-07 34 sites Stand-alone
    Other conditions: Visual Impairment Due to Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01136252

    Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 5 participants Est. completion 2011-10 1 site
    Other conditions: Age-Related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT01138514

    Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

    Not yet reported Padagis LLC 1555 participants Est. completion 2010-10
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT01140243

    Infant Formula Supplemented With a Special Fat Formulation for Premature Infants Following Discharge From Hospital

    Not yet reported Materna Laboratories 31 participants Est. completion 2013-03 2 sites Stand-alone
    Other conditions: Premature Infants
    View official trial listing →
  • Completed NCT NCT01148511

    Comparison of Safety, Effectiveness and Quality of Life Outcomes Between Labeled Versus "Treat and Extend" Regimen in Turkish Patients With Choroidal Neovascularisation Due to Age-related Macular Degeneration (AMD)

    Not yet reported Novartis Pharmaceuticals 99 participants Est. completion 2012-04 8 sites Stand-alone
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01170767

    French Evaluation Group Avastin Versus Lucentis

    Not yet reported Hospices Civils de Lyon 501 participants Est. completion 2012-12 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01175395

    20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD)

    Not yet reported, Not yet reported University of Illinois at Chicago 10 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Age-Related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT01182636

    Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

    Not yet reported Teva Pharmaceuticals USA 601 participants Est. completion 2008-04 22 sites Stand-alone
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Status unknown NCT NCT01189526

    Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO)

    Not yet reported Seoul Retina Investigator Group 60 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Branch Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01201161

    Ranibizumab for Diabetic Traction Retinal Detachment

    Not yet reported University of Sao Paulo 19 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Diabetic Retinopathy, Retinal Detachment
    View official trial listing →
  • Completed NCT NCT01217944

    Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia

    Not yet reported Novartis Pharmaceuticals 277 participants Est. completion 2012-08 74 sites Stand-alone
    Other conditions: Pathological Myopia
    View official trial listing →
  • Withdrawn NCT NCT01228643

    Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs

    Not yet reported Azidus Brasil Est. completion 2011-12 1 site
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Status unknown NCT NCT01246089

    Ranibizumab for Myopic Neovascularization

    Not yet reported Instituto de Olhos de Goiania 20 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Myopic Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT01256632

    Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy

    Not yet reported Vision Research Foundation 40 participants Est. completion 2010-10 1 site
    Other conditions: Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT01260948

    10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions

    Not yet reported Teva Pharmaceuticals USA 26 participants Est. completion 2006-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01273038

    Clinical Investigation for New Filter to Ostomy Bags

    Not yet reported Coloplast A/S 20 participants Est. completion 2011-03 1 site Stand-alone
    Other conditions: Colostomy
    View official trial listing →
  • Completed NCT NCT01282801

    Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

    Not yet reported Teva Pharmaceuticals USA 18 participants Est. completion 2002-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01282814

    Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Sprinkle Study

    Not yet reported Teva Pharmaceuticals USA 24 participants Est. completion 2003-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01304693

    ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients

    Not yet reported, Not yet reported Alcon Research 376 participants Est. completion 2013-03
    Other conditions: Exudative Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01315275

    A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular Edema

    Not yet reported Novartis Pharmaceuticals 394 participants Est. completion 2012-08 43 sites Stand-alone
    Other conditions: Visual Impairment, Macular Edema
    View official trial listing →
  • Completed NCT NCT01318941

    Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting

    Novartis Pharmaceuticals 30490 participants Est. completion 2016-04 463 sites
    Other conditions: Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion
    View official trial listing →
  • Terminated NCT NCT01319188

    Ranibizumab and the Risk of Arterial Thromboembolic Events

    Not yet reported Ural State Medical University 380 participants Est. completion 2015-04 2 sites
    Cardiovascular disease Other conditions: Age-related Macular Degeneration, Cerebrovascular Disorders
    View official trial listing →
  • Completed NCT NCT01332578

    A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies

    Not yet reported GlaxoSmithKline 25 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Influenza, Common Cold
    View official trial listing →
  • Completed NCT NCT01334879

    High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

    Not yet reported The New York Eye Cancer Center 10 participants Est. completion 2012-11 1 site
    Other conditions: Radiation Retinopathy
    View official trial listing →
  • Completed NCT NCT01353755

    2nd Pivotal Study rPhleum - Adults and Adolescents With Rhinoconjunctivitis +/-Controlled Asthma

    Not yet reported Allergopharma GmbH & Co. KG 195 participants Est. completion 2014-09 1 site
    Other conditions: Rhinoconjunctivitis, Allergic Asthma
    View official trial listing →
  • Completed NCT NCT01370135

    Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma

    Not yet reported University of Luebeck 20 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Neovascular Glaucoma, Rubeosis
    View official trial listing →
  • Completed NCT NCT01397409

    Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)

    Not yet reported Allergan 271 participants Est. completion 2014-04-30 8 sites
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT01402544

    Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

    Not yet reported, Not yet reported University of California, San Diego 20 participants Est. completion 2015-03 4 sites
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01415557

    Effect of Regular Consumption of Micronutrient Fortified Beverage on the Micronutrient Status of Indian Schoolchildren

    Not yet reported Mondelēz International, Inc. 227 participants Est. completion 2012-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01439438

    Topiramate Bioequivalence Study Brazil - Fast

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2011-09-11 1 site
    Other conditions: Epilepsy, Tonic-Clonic
    View official trial listing →
  • Completed NCT NCT01445899

    PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

    Not yet reported Quark Pharmaceuticals 258 participants Est. completion 2013-11 51 sites Stand-alone
    Other conditions: Choroidal Neovascularization, Diabetic Retinopathy, Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01448031

    A Healthy Female and Male Volunteers Aspirin Study

    Not yet reported AstraZeneca 54 participants Est. completion 2012-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01469156

    Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy

    Not yet reported, Not yet reported Southeast Retina Center, Georgia 20 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Polypoidal Choroidal Vasculopathy
    View official trial listing →
  • Completed NCT NCT01476449

    Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema

    Not yet reported Retina Vitreous Associates of Florida 20 participants Est. completion 2016-09 2 sites Stand-alone
    Other conditions: Diabetic Retinopathy, Macular Edema
    View official trial listing →
  • Status unknown NCT NCT01521819

    Iray for Vascularized Pigment Epithelial Detachment (VPED) Secondary to Age Related Macular Degeneration

    Not yet reported Oraya Therapeutics, Inc. 12 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Retinal Pigment Epithelial Detachment With Vascularization, Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01578252

    Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

    Not yet reported IPCA Laboratories Ltd. 48 participants Est. completion 2011-09 1 site
    Other conditions: Fasting State
    View official trial listing →
  • Completed NCT NCT01600274

    Bioavailability Study With Oral Single Dose Administration of Ethinylestradiol and Dienogest

    Not yet reported Pharbil Waltrop GmbH 20 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Focus: Bioequivalence
    View official trial listing →
  • Completed NCT NCT01603173

    Bioequivalence Study of Quetiapine Fumarate Tablets 25 mg Under Fasting Condition

    Not yet reported IPCA Laboratories Ltd. 54 participants Est. completion 2011-11 1 site
    Other conditions: Fasting State
    View official trial listing →
  • Completed NCT NCT01608217

    Delta-THC in Dementia

    Not yet reported Radboud University Medical Center 50 participants Est. completion 2014-06 2 sites
    Other conditions: Behavioural Disturbances, Pain, Dementia, Alzheimer's Dementia, Vascular Dementia
    View official trial listing →
  • Status unknown NCT NCT01635790

    Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Diabetic Macular Edema (BRDME)

    Not yet reported, Not yet reported Prof. dr. R.O. Schlingemann 246 participants 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Status unknown NCT NCT01635803

    Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)

    Not yet reported, Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 296 participants 1 site
    Other conditions: Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT01661946

    Bloodstream Absorption of Avastin and Lucentis After Injection Into the Eye

    Not yet reported Queen's University 10 participants Est. completion 2013-08 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Status unknown NCT NCT01676506

    Genetic Polymorphisms in Ranibizumab Treatment in Wet Age-Related Macular Degeneration (AMD)

    Not yet reported Russian Academy of Medical Sciences 300 participants Est. completion 2015-10 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01682577

    Bioequivalence Study of Two Formulations of Perindopril 4 mg Tablet Under Fasting Condition

    Not yet reported Dexa Medica Group 18 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01697384

    Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer

    Not yet reported Endo USA Inc., a Keenova Therapeutics Company 138 participants Est. completion 2004-10 Stand-alone
    Other conditions: Prostate Cancer, Adenocarcinoma of the Prostate
    View official trial listing →
  • Status unknown NCT NCT01715168

    A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

    Not yet reported Azaya Therapeutics, Inc. 40 participants Est. completion 2015-12 2 sites
    Other conditions: Ovarian Cancer, Malignant Female Reproductive System Neoplasm, Cancer, Ovarian Tumor, Ovarian Epithelial Cancer Recurrent
    View official trial listing →
  • Completed NCT NCT01717235

    Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

    Not yet reported Lupin Ltd. 12 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Pharmacokinetic Study
    View official trial listing →
  • Completed NCT NCT01735344

    Bioequivalence Study of Lisinopril Tablets 40 mg Under Fed Condition

    Not yet reported IPCA Laboratories Ltd. 40 participants Est. completion 2012-08 1 site
    Other conditions: Fed
    View official trial listing →
  • Completed NCT NCT01738893

    Bioequivalence Study of 300 mg Gabapentin

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2011-01-22 Stand-alone
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT01745575

    Bioequivalence Trial of Alprazolam 2 mg Tablets

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2010-04-05 Stand-alone
    Other conditions: Anxiety Disorders
    View official trial listing →
  • Completed NCT NCT01745614

    Bioequivalence Study of Nimesulide 100 mg Tablets

    Not yet reported GlaxoSmithKline 28 participants Est. completion 2010-07-26 Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT01749228

    Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fed Condition

    Not yet reported IPCA Laboratories Ltd. 36 participants Est. completion 2012-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01767584

    Bioequivalence Study of Cephalexin Tablets 1g

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2009-04-14 Stand-alone
    Other conditions: Infections, Respiratory Tract
    View official trial listing →
  • Completed NCT NCT01770860

    A Test of Different Kinds of Bandages on Healing of Wounds

    Not yet reported Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. 46 participants Est. completion 2013-02 1 site
    Other conditions: Wound Healing
    View official trial listing →
  • Completed NCT NCT01772212

    Bioequivalence Study for Terbinafine 250 mg

    Not yet reported GlaxoSmithKline 30 participants Est. completion 2011-03-15 Stand-alone
    Other conditions: Mycoses
    View official trial listing →
  • Completed NCT NCT01779947

    Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo

    Not yet reported Amneal Pharmaceuticals, LLC 519 participants Est. completion 2012-12 25 sites Stand-alone
    Other conditions: Atrophic Vaginitis Due to Menopause
    View official trial listing →
  • Completed NCT NCT01780935

    Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degeneration

    Not yet reported Novartis Pharmaceuticals 671 participants Est. completion 2015-07-09 92 sites Stand-alone
    Other conditions: Neovascular Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01788384

    Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris

    Not yet reported Watson Laboratories, Inc. 708 participants Est. completion 2012-12
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT01806688

    Effect of Snacks on Appetite Control

    Not yet reported St. Boniface Hospital 46 participants Est. completion 2014-08-23 1 site Stand-alone
    Other conditions: Healthy Canadians, Appetite Control
    View official trial listing →
  • Completed NCT NCT01810042

    Indocyanine Angiographic Changes of Choroidal Neovascularization by Ranibizumab

    Not yet reported Pusan National University Hospital 49 participants Est. completion 2013-02 2 sites Stand-alone
    Other conditions: Exudative Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01823965

    Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

    Not yet reported Poitiers University Hospital 35 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Status unknown NCT NCT01824043

    Use of Intravitreal Ranibizumab in the Treatment of Vitreous Hemorrhage

    Not yet reported Hospital Regional de São José - Dr. Homero de Miranda Gomes 20 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Diabetic Retinopathy, Vitreous Hemorrhage
    View official trial listing →
  • Completed NCT NCT01831661

    Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fasting Condition

    Not yet reported IPCA Laboratories Ltd. 48 participants Est. completion 2013-02 1 site
    Other conditions: Fasting
    View official trial listing →
  • Completed NCT NCT01831700

    Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions

    Not yet reported IPCA Laboratories Ltd. 48 participants Est. completion 2012-10 1 site
    Other conditions: Fasting
    View official trial listing →
  • Completed NCT NCT01831947

    Efficacy Study of Ranibizumab on Patients With Age-related Macular Degeneration.

    Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 40 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01835067

    Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD

    Not yet reported, Not yet reported King's College Hospital NHS Trust 55 participants Est. completion 2019-12 5 sites Stand-alone
    Other conditions: Exudative Macular Degeneration, Retinal Hemorrhage
    View official trial listing →
  • Completed NCT NCT01846273

    Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)

    Not yet reported Novartis Pharmaceuticals 321 participants Est. completion 2017-03-02 41 sites Stand-alone
    Other conditions: Age-related Macular Degeneration, Polypoidal Choroidal Vasculopathy
    View official trial listing →
  • Completed NCT NCT01876550

    A Study to Evaluate the Safety and Bioequivalence of Mupirocin Calcium Cream, 2% and Bactroban® Cream and Compare Both to a Vehicle in Treatment of Secondarily Infected Traumatic Skin Lesions.

    Not yet reported Sun Pharmaceutical Industries, Inc. 1902 participants Est. completion 2019-05-06
    Other conditions: Secondarily Infected Traumatic Skin Lesions
    View official trial listing →
  • Completed NCT NCT01884896

    Bioequivalence Study of Metoprolol Succinate Extended Release Tablets 200 mg Under Fasting Conditions

    Not yet reported IPCA Laboratories Ltd. 48 participants Est. completion 2013-03 1 site
    Other conditions: Fasting
    View official trial listing →
  • Completed NCT NCT01891864

    Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

    Not yet reported Sandoz 531 participants Est. completion 2015-03 74 sites
    Other conditions: Chronic Stable Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01914159

    Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study

    Not yet reported University Hospital, Bonn 24 participants Est. completion 2016-03 3 sites Stand-alone
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01926977

    Evaluation of Pain and Inflammation After Injection of Lucentis vs Eylea for Treatment of Wet Macular Degeneration

    Not yet reported, Not yet reported Arshad Khanani 100 participants Est. completion 2014-05 1 site
    Other conditions: Neovascular Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01933152

    Study to Assess the EffectiVeness of exIsting Anti-vascular Endothelial groWth Factor (Anti-VEGF) Treatment Regimens in Patients With Wet Age-related Macular Degeneration

    Bayer 137 participants Est. completion 2013-04 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01941329

    Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy.

    Not yet reported, Not yet reported Association for Innovation and Biomedical Research on Light and Image 94 participants Est. completion 2017-10 13 sites Stand-alone
    Other conditions: High Risk Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT01945866

    Phase II Combination Steroid and Anti-VEGF for Persistent DME

    Not yet reported Jaeb Center for Health Research 129 participants Est. completion 2017-06-05 56 sites Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT01957475

    Investigation of Two Newly Developed 2-piece Convex Baseplates in Subjects With Ileostomy

    Not yet reported Coloplast A/S 20 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Stoma - Ileostomy
    View official trial listing →
  • Completed NCT NCT01957553

    Investigating the Safety and Performance of a New 2-piece Ostomy Product Compared With SenSura Click 2-piece

    Not yet reported Coloplast A/S 130 participants Est. completion 2013-12 17 sites Stand-alone
    Other conditions: Ileostomy - Stoma
    View official trial listing →
  • Completed NCT NCT01958918

    Efficacy of Ranibizumab Prn Treatment Compared to Aflibercept Bimonthly Intravitreal Injections on Retinal Thickness Stability in Patients With Wet AMD

    Not yet reported Novartis Pharmaceuticals 712 participants Est. completion 2017-05-29 68 sites Stand-alone
    Other conditions: Neovascular Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01966120

    Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

    Not yet reported Biofrontera Bioscience GmbH 87 participants Est. completion 2015-04 1 site
    Other conditions: Actinic Keratosis
    View official trial listing →
  • Completed NCT NCT01968486

    Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

    Not yet reported University of Campania Luigi Vanvitelli 60 participants Est. completion 2013-07 Stand-alone
    Other conditions: Myopia, Degenerative
    View official trial listing →
  • Completed NCT NCT01972763

    Ranibizumab for Recalcitrant Wet Age-related Macular Degeneration in Eyes Previously Switched From Bevacizumab and/or Ranibizumab to Aflibercept.

    Not yet reported, Not yet reported Northern California Retina Vitreous Associates 12 participants Est. completion 2018-07 1 site
    Other conditions: Recalcitrant Wet Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT01972789

    Comparison of Treatment Regimens Using Ranibizumab: Intensive (Resolution of Intra- and Sub-retinal Fluid) vs Relaxed (Resolution of Intra-retinal Fluid and/or Sub-retinal Fluid >200µm at the Foveal Centre)

    Not yet reported Novartis Pharmaceuticals 349 participants Est. completion 2017-02-28 16 sites Stand-alone
    Other conditions: Subfoveal Choroidal Neovascularization CNV Secondary to Wet Age-related Macular Degeneration AMD
    View official trial listing →
  • Terminated NCT NCT01994863

    Safety and Performance Investigation of a New 1-piece Ostomy Product Compared to Standard of Care 1-piece in Subjects With Ileostomy

    Not yet reported Coloplast A/S 23 participants Est. completion 2012-11 1 site Stand-alone
    Other conditions: Ileostomy - Stoma
    View official trial listing →
  • Status unknown NCT NCT02005432

    PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic Retinopathy

    Not yet reported University of Sao Paulo 31 participants 1 site
    Other conditions: Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT02033031

    Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion

    Not yet reported Medical University of Vienna 28 participants Est. completion 2013-02 1 site
    Other conditions: Branch Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT02034006

    A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

    Not yet reported Novartis Pharmaceuticals 200 participants Est. completion 2016-07-15 31 sites Stand-alone
    Other conditions: Choroidal Neovascularization Secondary to Pathologic Myopia
    View official trial listing →
  • Withdrawn NCT NCT02055911

    Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema

    Not yet reported Federal University of São Paulo Est. completion 2015-07 1 site Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02060604

    Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

    Not yet reported Università degli Studi di Brescia 60 participants Est. completion 2014-01 1 site Stand-alone
    Other conditions: Wet Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02063646

    Effect of a Polyphenol-rich Food Supplement on Cognitive Function in Healthy Aging Adults

    Not yet reported Neurophenols Consortium 204 participants Est. completion 2015-03 2 sites Stand-alone
    Other conditions: Healthy Elderly
    View official trial listing →
  • Completed NCT NCT02072954

    Bioequivalence Fasting Study in Patients

    Not yet reported, Not yet reported Amneal Pharmaceuticals, LLC 48 participants Est. completion 2014-06 2 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Status unknown NCT NCT02081339

    Cohort Study of the Clinical Course of Macular Diseases in Japanese

    Kyoto University, Graduate School of Medicine 1000 participants Est. completion 2024-03 1 site
    Other conditions: Macular Disease
    View official trial listing →
  • Completed NCT NCT02081495

    A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

    Not yet reported Janssen Research & Development, LLC 35 participants Est. completion 2015-11 6 sites Stand-alone
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02086227

    Bioequivalence of Fresenius Kabi USA, LLC Glucagon for SC Injection Compared to Glucagon for Injection (Bedford Laboratories)

    Not yet reported Fresenius Kabi USA, LLC 32 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Hypoglycemia
    View official trial listing →
  • Withdrawn NCT NCT02127684

    Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing

    Not yet reported Maturi, Raj K., M.D., P.C. Est. completion 2015-11 1 site Stand-alone
    Other conditions: Persistent Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02130024

    A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients

    Not yet reported Novartis Pharmaceuticals 281 participants Est. completion 2017-11-15 22 sites Stand-alone
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02140151

    Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

    Not yet reported, Not yet reported Southern California Desert Retina Consultants, MC 108 participants Est. completion 2020-07-09 4 sites
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02162888

    A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer Patients

    Not yet reported Eagle Pharmaceuticals, Inc. 81 participants Est. completion 2014-11 10 sites
    Other conditions: Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is Appropriate
    View official trial listing →
  • Completed NCT NCT02174211

    A Pharmacokinetic Study: Ranibizumab, Aflibercept and the Effect of Vitrectomy.

    Not yet reported King's College Hospital NHS Trust 59 participants Est. completion 2020-12 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02175940

    VEGF and PEDF in Patients With Myopic Choroidal Neovascularization

    Università degli Studi di Brescia 40 participants Est. completion 2014-05 1 site
    Other conditions: Myopic Choroidal Neovascularization, VEGF Aqueous Level, PEDF Aqueous Level
    View official trial listing →
  • Completed NCT NCT02181517

    A Study of Abicipar Pegol in Patients With Neovascular Age-related Macular Degeneration

    Not yet reported Allergan 25 participants Est. completion 2015-03 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02210689

    A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

    Not yet reported Actavis Inc. 604 participants Est. completion 2014-12 18 sites Stand-alone
    Other conditions: BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and Consistency, Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe, Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe
    View official trial listing →
  • Terminated NCT NCT02214628

    Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

    Not yet reported Ophthotech Corporation 101 participants Est. completion 2016-12 13 sites
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02230696

    Comparative Safety and Efficacy of Two Steroid Treatments in the Relief of the Symptoms of Seasonal Allergic Rhinitis

    Not yet reported Padagis LLC 951 participants Est. completion 2015-02 30 sites Stand-alone
    Other conditions: Seasonal Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT02230904

    A Study to Compare the Adhesiveness of 2 Different Rotigotine Patches Used for the Treatment of Parkinson's Disease

    Not yet reported UCB BIOSCIENCES GmbH 57 participants Est. completion 2014-12 11 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02232087

    Single Blind Cross-over Dose Response Study in Subjects of Two Inhalers of Salmeterol and Fluticasone Propionate

    Not yet reported Kindeva Drug Delivery 52 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02243878

    Stereotactic Radiotherapy for Wet AMD (STAR)

    Not yet reported King's College Hospital NHS Trust 411 participants Est. completion 2024-04 30 sites Stand-alone
    Other conditions: Neovascular (Wet) Age-related Macular Degeneration (AMD)
    View official trial listing →
  • Completed NCT NCT02243956

    Effects on Cognitive Functions and Mood of Food Products Rich in Polyphenols

    Not yet reported Lund University 38 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Cognitive Performance, Mood, Cardiometabolic Risk Markers
    View official trial listing →
  • Completed NCT NCT02249689

    Three-month Clinical Evaluation of Silicone Hydrogel Definitive 65 Contact Lenses

    Not yet reported Contamac Ltd 60 participants Est. completion 2014-05 2 sites Stand-alone
    Other conditions: Ametropia
    View official trial listing →
  • Completed NCT NCT02257632

    Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration

    Not yet reported Novartis Pharmaceuticals 41 participants Est. completion 2017-06-08 6 sites Stand-alone
    Other conditions: Wet Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02260063

    Relative Bioavailability of Epinastine Syrup Compared to Tablets in Healthy Volunteers

    Not yet reported Boehringer Ingelheim 24 participants
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02260544

    Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

    Not yet reported Dr. Reddy's Laboratories Limited 49 participants Est. completion 2015-08 11 sites Stand-alone
    Other conditions: Ovarian Epithelial Cancer Recurrent
    View official trial listing →
  • Completed NCT NCT02262260

    Compare Safety/Efficacy of Labeled vs Wait-Extend Regimen of Lucentis in Turkish Patients With VI Due to DME

    Not yet reported Novartis Pharmaceuticals 87 participants Est. completion 2017-09-12 9 sites Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02265913

    Comparative Safety and Efficacy of Two Antiviral Treatments in the Treatment of Recurrent Herpes Simplex Labialis

    Not yet reported Padagis LLC 4076 participants Est. completion 2017-11-21 1 site Stand-alone
    Other conditions: Herpes Labialis
    View official trial listing →
  • Completed NCT NCT02274259

    Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen

    Not yet reported Anders Kvanta 40 participants Est. completion 2016-12 1 site
    Other conditions: Central Retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT02278380

    Different Glycemic Index (GI) Values in 7 Food Products

    Not yet reported Danone Asia Pacific Holdings Pte, Ltd. 15 participants Est. completion 2015-01 1 site
    Other conditions: Glycemic Index
    View official trial listing →
  • Completed NCT NCT02280876

    Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)

    Not yet reported, Not yet reported Universidad Austral de Chile 30 participants Est. completion 2015-05 1 site
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT02288858

    To Evaluate the Effects of Viviscal Oral Supplements When Used by Females With Self-perceived Thinning Hair

    Not yet reported Irish Response t/a Lifes2good 96 participants Est. completion 2011-11 1 site
    Other conditions: Hair Thinning
    View official trial listing →
  • Completed NCT NCT02291887

    Genetic Analysis of Patients Responsive to Ranibizumab But Resistant to Aflibercept

    Associated Retinal Consultants, Michigan 13 participants Est. completion 2015-07-01 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT02296567

    Comparison of Pharmacokinetics of and Effect on Systemic VEGF Levels in Age Related Macular Degeneration Patients

    Not yet reported, Not yet reported East Florida Eye Institute 80 participants Est. completion 2016-07 1 site
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02309281

    Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab

    Not yet reported Vista Klinik 33 participants Est. completion 2014-07
    Other conditions: Neovascular Age-related Macular Degeneration
    View official trial listing →
  • Status unknown NCT NCT02328209

    Evaluation of the Simplified Treat And Extend Regimen Using Ranibizumab in Exudative Age Related Macular Degeneration

    Not yet reported Mie University 50 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Exudative Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02329132

    Change Oxygen Consumption Following Intravitreal Treatment of Lucentis (Ranibizumab) in Eyes With Diabetic Macular Edema

    Kagawa University 30 participants Est. completion 2018-02-28 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02342392

    Intralesional Ranibizumab on Pterygium Vascularity, Size and Recurrence Rate: a Pilot Study

    Not yet reported, Not yet reported Universiti Sains Malaysia 36 participants Est. completion 2014-09
    Other conditions: Pterygium
    View official trial listing →
  • Withdrawn NCT NCT02349516

    Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

    Not yet reported Starr Muscle Est. completion 2015-09 1 site Stand-alone
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT02350296

    Crossover, Single Dose Randomized, Bioequivalence of Ketoprofen Lysine Salt Immediate Release vs Oral Solution

    Not yet reported Dompé Farmaceutici S.p.A 30 participants Est. completion 2015-04-22 1 site Stand-alone
    Other conditions: Pain Disorders
    View official trial listing →
  • Completed NCT NCT02359201

    Assessment of V0018 1.5 mg Effect on Craving

    Not yet reported Pierre Fabre Medicament 30 participants Est. completion 2015-04 1 site Stand-alone
    Other conditions: Smoking
    View official trial listing →
  • Completed NCT NCT02375971

    RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity

    Not yet reported Novartis Pharmaceuticals 224 participants Est. completion 2017-12-14 86 sites Stand-alone
    Other conditions: Retinopathy of Prematurity
    View official trial listing →
  • Completed NCT NCT02392819

    Effects on Metabolism and Cognitive Functions of a Commonly Used Commercial Food Supplement

    Not yet reported Lund University 22 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Postprandial Blood Glucose Regulation
    View official trial listing →
  • Completed NCT NCT02397954

    A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

    Not yet reported Ophthotech Corporation 4 participants Est. completion 2015-10-23 1 site Stand-alone
    Other conditions: Idiopathic Polypoidal Choroidal Vasculopathy
    View official trial listing →
  • Completed NCT NCT02411955

    A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris

    Not yet reported Sun Pharmaceutical Industries, Inc. 1077 participants Est. completion 2015-02
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Terminated NCT NCT02417129

    BI 695500 vs Rituxan First Line Treatment in Patients With Low Tumor Burden Follicular Lymphoma

    Not yet reported Boehringer Ingelheim 2 participants Est. completion 2015-12 21 sites
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Status unknown NCT NCT02462304

    To Compare Anti-VEGF Monotherapy With Anti-VEGF and EPM Grid Laser Combination Therapy for Diabetic Macular Edema

    Not yet reported The University of Hong Kong 60 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Diabetic Macula Edema
    View official trial listing →
  • Completed NCT NCT02462928

    A Safety and Efficacy Study of Abicipar Pegol in Participants With Neovascular Age-related Macular Degeneration

    Not yet reported Allergan 939 participants Est. completion 2019-06-19 151 sites
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02484690

    A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD)

    Not yet reported Hoffmann-La Roche 273 participants Est. completion 2017-09-26 52 sites Stand-alone
    Other conditions: Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT02515305

    Comparative Safety and Efficacy of Two Treatments in the Treatment of Acne Vulgaris

    Not yet reported Padagis LLC 890 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Acne
    View official trial listing →
  • Completed NCT NCT02559180

    Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab

    Not yet reported Rishi Singh 20 participants Est. completion 2020-12 1 site
    Other conditions: Diabetic Retinopathy, Macular Edema
    View official trial listing →
  • Completed NCT NCT02593500

    Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg

    Not yet reported Reig Jofre Group 57 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Allergy
    View official trial listing →
  • Completed NCT NCT02611804

    A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp

    Not yet reported Teva Pharmaceuticals USA 492 participants Est. completion 2016-08 30 sites
    Other conditions: Actinic Keratosis
    View official trial listing →
  • Completed NCT NCT02629562

    Pharmacokinetic and Pharmacodynamics of B12019 and Neulasta® in Healthy Subjects

    Not yet reported Cinfa Biotech 172 participants 1 site
    Other conditions: Clinical Pharmacology
    View official trial listing →
  • Withdrawn NCT NCT02634970

    CANadian Study in Patients With Wet AMD, Evaluating the Efficacy and Safety of Switching From Intravitreal Aflibercept to RanIbizumab

    Not yet reported Novartis Pharmaceuticals Est. completion 2017-12 Stand-alone
    Other conditions: Wet Age-related Macular Degeneration (Wet AMD)
    View official trial listing →
  • Completed NCT NCT02647515

    Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma

    Not yet reported Ruijin Hospital 18 participants Est. completion 2014-12 Stand-alone
    Other conditions: Diabetic Retinopathy, Glaucoma, Neovascular
    View official trial listing →
  • Completed NCT NCT02649556

    A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

    Not yet reported Philip Morris Products S.A. 672 participants Est. completion 2017-12-20 19 sites
    Other conditions: Smoking
    View official trial listing →
  • Status unknown NCT NCT02651168

    Predictors of Treatment Response to Aflibercept and Aqueous Cytokine Levels in Patients With Persistent Diabetic Macular Edema Following Treatment With Ranibizumab: An Interventional Prospective Study

    Not yet reported Unity Health Toronto 50 participants Est. completion 2018-06
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02668653

    Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML)

    Not yet reported Daiichi Sankyo 539 participants Est. completion 2023-06-16 244 sites
    Other conditions: Acute Myeloid Leukemia, Leukemia
    View official trial listing →
  • Terminated NCT NCT02684084

    Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema

    Not yet reported North Toronto Eye Care Laser and Eye Specialists 5 participants Est. completion 2016-12 2 sites
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02699450

    A Study of Faricimab (RO6867461) in Participants With Center-Involving Diabetic Macular Edema

    Not yet reported Hoffmann-La Roche 229 participants Est. completion 2017-12-14 60 sites Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT02713802

    Pilot Study of Bioequivalence of Cudafol(R) and Diprivan(R) Administered as Single Intravenous Doses in Healthy Subjects

    Not yet reported Cuda Anesthetics, LLC 8 participants Est. completion 2016-04 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT02750709

    Bioequivalence Study of Two Nitisinone Formulations Compared to Orfadin

    Not yet reported Cycle Pharmaceuticals Ltd. 24 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Hereditary Tyrosinemia, Type I
    View official trial listing →
  • Completed NCT NCT02751489

    Human Phototoxicity Test

    Not yet reported Bayer 35 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Sunscreening Agents
    View official trial listing →
  • Completed NCT NCT02754102

    Human Phototoxicity Test

    Not yet reported Bayer 35 participants Est. completion 2016-05-06 1 site Stand-alone
    Other conditions: Sunscreening Agents
    View official trial listing →
  • Status unknown NCT NCT02806752

    Intravitreal Ranibizumab and TA Combination Therapy vs. Ranibizumab Monotherapy in Polypoidal Choroidal Vasculopathy

    Not yet reported Aier School of Ophthalmology, Central South University 120 participants Est. completion 2019-12 7 sites Stand-alone
    Other conditions: Wet Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02840461

    Clinical Endpoint Study of Ivermectin 1% Cream

    Not yet reported Actavis Inc. 630 participants Est. completion 2016-12 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02857738

    Sun Protection Factor (SPF) - Static and Water Resistant Assay

    Not yet reported Bayer 12 participants Est. completion 2015-06-10 1 site Stand-alone
    Other conditions: Sunscreen Agents
    View official trial listing →
  • Completed NCT NCT02886702

    A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis

    Not yet reported Fougera Pharmaceuticals Inc. 855 participants Est. completion 2017-08-02 30 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02886715

    A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris

    Not yet reported Fougera Pharmaceuticals Inc. 1110 participants Est. completion 2017-05-31 25 sites
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT02902302

    Bioequivalence Study of Ibuprofen 400 mg/10 mL Oral Suspension vs. MOMENTACT 400 mg Film-coated Tablet

    Not yet reported Aziende Chimiche Riunite Angelini Francesco S.p.A 60 participants Est. completion 2016-07 1 site
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT02928484

    Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function

    Not yet reported, Not yet reported Biopolis S.L. 60 participants Est. completion 2017-12 1 site
    Other conditions: Signs and Symptoms, Digestive, Dyspepsia
    View official trial listing →
  • Completed NCT NCT02937636

    To Investigate the Gingivitis Efficacy of a Stannous Fluoride Dentifrice in a Chinese Population

    Not yet reported GlaxoSmithKline 128 participants Est. completion 2017-12-22 1 site Stand-alone
    Other conditions: Gingivitis
    View official trial listing →
  • Status unknown NCT NCT02941159

    SF2000SD Clinical Trial in Zambia

    Not yet reported Tropical Diseases Research Centre, Zambia 43 participants Est. completion 2018-02 1 site
    Other conditions: Good Health
    View official trial listing →
  • Completed NCT NCT02944227

    Efficacy of Fixed Monthly Dosing of Ranibizumab in Neovascular Age-related Macular Degeneration

    Not yet reported Seoul National University Hospital 20 participants Est. completion 2017-08-21 1 site Stand-alone
    Other conditions: Wet Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02950883

    Saline Hypertonic in Preschoolers + CT

    Not yet reported, Not yet reported University of Washington, the Collaborative Health Studies Coordinating Center 116 participants Est. completion 2021-06-25 25 sites
    Other conditions: Cystic Fibrosis
    View official trial listing →
  • Completed NCT NCT02978508

    Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies.

    Not yet reported Mayne Pharma International Pty Ltd 140 participants Est. completion 2017-05 3 sites Stand-alone
    Other conditions: Scabies
    View official trial listing →
  • Completed NCT NCT02982772

    Patch Study - Intervention for HIV Positive Smokers

    Not yet reported dr. maria miguez 488 participants Est. completion 2021-05-31 1 site Stand-alone
    Other conditions: Smoking Cessation, HIV
    View official trial listing →
  • Completed NCT NCT02989909

    Clinical Evaluation of CATS Tonometer Prism

    Not yet reported Intuor Technologies, Inc. 86 participants Est. completion 2017-11 1 site Stand-alone
    Other conditions: Ocular Hypertension
    View official trial listing →
  • Completed NCT NCT02992691

    Efficacy of Three Experimental Toothpastes to Remove Plaque

    Not yet reported GlaxoSmithKline 75 participants Est. completion 2017-02-02 1 site Stand-alone
    Other conditions: Dental Plaque
    View official trial listing →
  • Completed NCT NCT03005041

    Consumer Perception of an Experimental Mouthwash After a Single Use in Dry Mouth Subjects

    Not yet reported GlaxoSmithKline 56 participants Est. completion 2016-10-19 1 site Stand-alone
    Other conditions: Xerostomia
    View official trial listing →
  • Completed NCT NCT03007992

    Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer

    Not yet reported Johannes Gutenberg University Mainz 9 participants Est. completion 2019-03-02 8 sites Stand-alone
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT03037307

    A Clinical Bite Force Study of Two Marketed Adhesives Against no Adhesive

    Not yet reported GlaxoSmithKline 44 participants Est. completion 2017-05-04 1 site Stand-alone
    Other conditions: Denture Retention
    View official trial listing →
  • Completed NCT NCT03038880

    Study to Evaluate Faricimab (RO6867461; RG7716) for Extended Durability in the Treatment of Neovascular Age Related Macular Degeneration

    Not yet reported Hoffmann-La Roche 76 participants Est. completion 2018-03-29 25 sites
    Other conditions: Neovascularization, Choroidal, Macular Degeneration, Age-Related
    View official trial listing →
  • Completed NCT NCT03071055

    Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF

    Not yet reported Southeast Clinical Research Associates, LLC 20 participants Est. completion 2019-06-03 2 sites Stand-alone
    Other conditions: Exudative Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03093181

    A Study to Evaluate of Cosmetic Benefit of a Moisturising Cream in People With Blemish Prone Skin

    Not yet reported GlaxoSmithKline 157 participants Est. completion 2017-08-28 1 site Stand-alone
    Other conditions: Skin Care
    View official trial listing →
  • Completed NCT NCT03093883

    Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers

    Not yet reported Azad Pharma AG 48 participants Est. completion 2018-06-26 1 site Stand-alone
    Other conditions: Heathy Volunteers
    View official trial listing →
  • Completed NCT NCT03103906

    Evaluation of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

    Not yet reported GlaxoSmithKline 106 participants Est. completion 2017-07-19 2 sites Stand-alone
    Other conditions: Skin Care
    View official trial listing →
  • Terminated NCT NCT03105609

    Enhancing the Lucentis (Ranibizumab) Management of Choroidal Neovascular Membranes With Hyperspectral Imaging

    Center for Eye Research Australia 4 participants Est. completion 2018-12-01 1 site
    Other conditions: Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT03116321

    Bioequivalence of Two Different Sources of Eslicarbazepine Acetate

    Not yet reported Bial - Portela C S.A. 24 participants Est. completion 2017-01-05
    Other conditions: Epilepsy
    View official trial listing →
  • Completed NCT NCT03119688

    To Assess the Mildness of a Cosmetic Cleanser in Healthy Participants Using the Forearm-Controlled Application Technique (FCAT)

    Not yet reported GlaxoSmithKline 50 participants Est. completion 2017-05-26 2 sites
    Other conditions: Skin Care
    View official trial listing →
  • Completed NCT NCT03150082

    Bioequivalence Study Between GR37547 500 Milligrams (mg) Tablet Versus Ciprofloxacin 500 mg Tablet Reference Product in Healthy Adult Subjects

    Not yet reported GlaxoSmithKline 26 participants Est. completion 2017-08-28 1 site
    Other conditions: Infections, Bacterial
    View official trial listing →
  • Completed NCT NCT03169959

    A Study to Evaluate the Food Effect on Drug Availability, Pharmacokinetic (PK) Properties, Safety and Tolerability of Two Different Dose Combination Therapy of Saxagliptin/Dapagliflozin/Metformin Extended-release (XR) Against Individual Component Co-administration.

    Not yet reported AstraZeneca 85 participants Est. completion 2017-08-03 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03200912

    An Equivalence Study of Generic Ingenol Mebutate Gel 0.015% and Picato Gel 0.015% in Subjects With Actinic Keratosis

    Not yet reported Actavis Inc. 507 participants Est. completion 2017-03-22 23 sites
    Other conditions: ACTINIC KERATOSIS
    View official trial listing →
  • Completed NCT NCT03209635

    Weissella Cibaria JW15 Consumption and NK Cell Activity

    Not yet reported Yonsei University 100 participants Est. completion 2017-03-20
    Other conditions: Immune Function
    View official trial listing →
  • Completed NCT NCT03214406

    Clinical Evaluation of the Efficacy of a Marketed Dentifrice on Plaque and Gingivitis

    Not yet reported Church & Dwight Company, Inc. 181 participants Est. completion 2010-08-03 1 site Stand-alone
    Other conditions: Plaque, Gingivitis
    View official trial listing →
  • Completed NCT NCT03233009

    To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test

    Not yet reported GlaxoSmithKline 43 participants Est. completion 2017-05-26 2 sites Stand-alone
    Other conditions: Skin Care
    View official trial listing →
  • Completed NCT NCT03238911

    Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia

    Not yet reported Pharmacosmos A/S 123 participants Est. completion 2018-06-19 16 sites Stand-alone
    Other conditions: Iron Deficiency Anaemia, Iron Deficiency Anemia
    View official trial listing →
  • Completed NCT NCT03261635

    Ranibizumab Plus Indomethacin

    Not yet reported Università degli Studi di Brescia 58 participants Est. completion 2017-07-25 Stand-alone
    Other conditions: Macular Edema
    View official trial listing →
  • Completed NCT NCT03272295

    A Nicotine Pharmacokinetics and Smoking Behaviour Study Examining Cigarette Ingredients

    Not yet reported British American Tobacco (Investments) Limited 40 participants Est. completion 2017-12-08 1 site Stand-alone
    Other conditions: Healthy Volunteers, Smoking
    View official trial listing →
  • Completed NCT NCT03272425

    Lesinurad/Allopurinol 200/300 Fixed-Dose Combination (FDC) Tablets Bioequivalence.

    Not yet reported Ardea Biosciences, Inc. 32 participants Est. completion 2017-10-04 1 site Stand-alone
    Other conditions: Gout
    View official trial listing →
  • Completed NCT NCT03291080

    Oral Liquid 13-cis-retinoic Acid (13-CRA)

    Not yet reported, Not yet reported Nova Laboratories Limited 20 participants Est. completion 2019-09-12 10 sites Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT03296072

    In Situ Erosion Study to Investigate the Effectiveness of an Experimental Toothpaste

    Not yet reported GlaxoSmithKline 62 participants Est. completion 2018-01-16 1 site Stand-alone
    Other conditions: Tooth Erosion
    View official trial listing →
  • Completed NCT NCT03302065

    Comparison of the Pharmacokinetics of Tiotropium Delivered From Test Inhaler Products With Reference

    Not yet reported Solventum US LLC 38 participants Est. completion 2017-01 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03311022

    Bioequivalence Study of Nefopam Hydrochloride 30mg Tablets vs Acupan® 30mg Tablets in Healthy Subjects

    Not yet reported Galen Limited 29 participants Est. completion 2015-12-21 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03323528

    Safety and Efficacy of a Sore Throat Lozenge DORITHRICIN in Patients With Acute Pharyngitis

    Not yet reported Medice Arzneimittel Pütter GmbH & Co KG 321 participants Est. completion 2017-11-15 1 site
    Other conditions: Pharyngitis
    View official trial listing →
  • Completed NCT NCT03324542

    Real World Outcomes of Intravitreal Anti-vascular Endothelial Growth Factors for Neovascular Age Related Macular Degeneration in Taiwan

    Changhua Christian Hospital 63 participants Est. completion 2017-10-15 1 site
    Other conditions: AMD
    View official trial listing →
  • Completed NCT NCT03334513

    Refractive Error and Biometry in Retinopathy of Prematurity

    San Ni Chen 35 participants Est. completion 2014-04-01
    Other conditions: Retinopathy of Prematurity
    View official trial listing →
  • Completed NCT NCT03340610

    IAI for Persistent DME After Treatment With Bevacizumab And Ranibizumab

    Not yet reported Southeast Retina Center, Georgia 30 participants Est. completion 2018-12-12 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT03376503

    Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients

    Not yet reported Nanogen Pharmaceutical Biotechnology Joint Stock Company 24 participants Est. completion 2017-11-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT03396250

    A Pharmacokinetic Trial of Naproxen Sodium and Diphenhydramine Hydrochloride Soft Capsules Versus Naproxen Sodium and Diphenhydramine Hydrochloride Tablets in Healthy Adult Subjects

    Not yet reported Bayer 36 participants Est. completion 2018-03-29 1 site Stand-alone
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT03406117

    A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

    Not yet reported Haus Bioceuticals 182 participants Est. completion 2016-07-21 Stand-alone
    Other conditions: Healthy, Atopic Dermatitis, Psoriasis
    View official trial listing →
  • Completed NCT NCT03423823

    Ziv-aflibercept Efficacy in Better Regulating AMD

    Not yet reported Kapil Kapoor 62 participants Est. completion 2020-06-26 1 site
    Other conditions: Wet Macular Degeneration, Wet Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03425552

    A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment

    Not yet reported, Not yet reported Pharmathen S.A. 70 participants Est. completion 2019-05-02 3 sites
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT03433378

    To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris

    Not yet reported Sun Pharmaceutical Industries, Inc. 700 participants Est. completion 2018-01-26 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT03439241

    Assessment of the Performance of a New Ostomy Device in Subjects Having an Ileostomy

    Not yet reported Coloplast A/S 20 participants Est. completion 2018-04-16 1 site Stand-alone
    Other conditions: Ileostomy - Stoma
    View official trial listing →
  • Status unknown NCT NCT03452657

    Multicenter Clinical Study of Anti-VEGF Treatment on High Risk Diabetic Retinopathy (DR)

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 118 participants Est. completion 2020-06 7 sites Stand-alone
    Other conditions: Diabetic Retinopathy, Ranibizumab
    View official trial listing →
  • Completed NCT NCT03457649

    IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers

    Not yet reported argenx 62 participants Est. completion 2017-02-21
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03458923

    Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.

    Not yet reported Cairo University 30 participants Est. completion 2018-06 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT03543137

    To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy Smokers

    Not yet reported GlaxoSmithKline 37 participants Est. completion 2018-11-12 1 site Stand-alone
    Other conditions: Tobacco Use Disorder
    View official trial listing →
  • Completed NCT NCT03587428

    Effect of Two Toothpastes on Bacteria in Saliva

    Not yet reported GlaxoSmithKline 15 participants Est. completion 2014-11-27 1 site Stand-alone
    Other conditions: Oral Health
    View official trial listing →
  • Completed NCT NCT03665714

    Effects of Immunonutrition (Impact Oral®) in Patients Undergoing Surgery for Gastrointestinal Cancer

    Not yet reported Société des Produits Nestlé (SPN) 308 participants Est. completion 2020-10-31 1 site Stand-alone
    Other conditions: Gastrointestinal Cancer
    View official trial listing →
  • Completed NCT NCT03672383

    Functional Study to Investigate the Efficacy of a New Medical Device (Modified Diprobase Formulation)

    Not yet reported Bayer 42 participants Est. completion 2018-10-17 1 site Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT03677934

    A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration

    Not yet reported Hoffmann-La Roche 415 participants Est. completion 2021-06-09 77 sites Stand-alone
    Other conditions: Neovascular Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03681548

    A Study of Doxorubicin Hydrochloride Liposome Injection in Subjects With Ovarian Cancer.

    Not yet reported Ayana Pharma Ltd., 52 participants Est. completion 2019-03-07 15 sites Stand-alone
    Other conditions: Ovarian Cancer Recurrent
    View official trial listing →
  • Completed NCT NCT03686930

    Multiple-Dose, Dose-Escalation Study to Evaluate the Safety/Tolerability and Pharmacokinetics of FP-045

    Not yet reported Foresee Pharmaceuticals Co., Ltd. 24 participants Est. completion 2018-08-10 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03705533

    Bioequivalence Study of Two Formulations of Telmisartan 80 mg Tablets in Healthy Adult Volunteers Under Fasting State

    Not yet reported Pharmtechnology LLC 26 participants Est. completion 2018-12-19 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03706781

    A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer

    Not yet reported Aziende Chimiche Riunite Angelini Francesco S.p.A 26 participants Est. completion 2018-03-30 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03711708

    Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets

    Not yet reported Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 36 participants Est. completion 2019-02-27 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03725501

    Evaluation of the Safety and Efficacy of ALS-L1023 Administered in Combination With Ranibizumab in Patients With Wet-AMD

    Not yet reported AngioLab, Inc. 126 participants Est. completion 2021-06-22 1 site Stand-alone
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03751202

    A Bioequivalence Study Between Fluticasone Salmeterol Xinafoate vs. ADVAIR DISKUS® in Healthy Volunteers

    Not yet reported Respirent Pharmaceuticals Co Ltd. 34 participants Est. completion 2018-12-11 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03757338

    Bioequivalence Study of a Test Capsule Formulation of Fingolimod With the Reference Capsule Formulation of Fingolimod

    Not yet reported Asofarma S.A.I. y C. 33 participants Est. completion 2016-01-26 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT03759860

    Laser (Selective Retina Therapy) and Drug Combined Intervention in Clinically Significant Diabetic Macular Edema

    Not yet reported CynosureLutronic 12 participants Est. completion 2020-07-30 1 site Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT03772158

    Cetirizine Chewable Bioequivalence and Food Effect Study

    Not yet reported Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division 40 participants Est. completion 2019-02-03 1 site
    Other conditions: Allergy
    View official trial listing →
  • Completed NCT NCT03802903

    Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax

    Not yet reported Orion Corporation, Orion Pharma 52 participants Est. completion 2019-04-29 1 site Stand-alone
    Other conditions: Cerumen Impaction of Both Ears
    View official trial listing →
  • Completed NCT NCT03805100

    Comparing the Efficacy and Safety of Biosimilar Candidate Xlucane Versus Lucentis® in Patients With nAMD

    Not yet reported Xbrane Biopharma AB 582 participants Est. completion 2021-11-11 102 sites Stand-alone
    Other conditions: Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03805802

    Influence of a Liquid Oat Bran Product on Blood Glucose in Patients With Poorly Controlled Type 2 Diabetes

    Not yet reported Stoffwechselzentrum Rhein - Pfalz 34 participants Est. completion 2020-04-01 1 site
    Type 2 diabetesMetabolic syndrome Other conditions: Obesity, Overweight
    View official trial listing →
  • Completed NCT NCT03820180

    A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

    Not yet reported Respirent Pharmaceuticals Co Ltd. 34 participants Est. completion 2019-02-19 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03844074

    A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

    Not yet reported Outlook Therapeutics, Inc. 61 participants Est. completion 2020-08-13 9 sites
    Other conditions: Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration, Wet Macular Degeneration
    View official trial listing →
  • Withdrawn NCT NCT03905564

    A Study to Investigate Differences in the Extent and Rate of Absorption of Doxylamine/Pyridoxine From 2 Different Products Under Fasting Conditions

    Not yet reported Grünenthal GmbH Est. completion 2020-06
    Other conditions: Bioavailability
    View official trial listing →
  • Completed NCT NCT03915340

    Bioequivalence Study of Two Formulations of Propafenone 300 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 32 participants Est. completion 2019-05-08 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT03944070

    Management of Patients With Neovascular Age-related Macular Degeneration Undergoing Cataract Surgery

    Not yet reported Ophthalmica Eye Institute 16 participants Est. completion 2020-01 1 site
    Other conditions: Wet Macular Degeneration, Cataract Extraction
    View official trial listing →
  • Completed NCT NCT03951051

    The Bioequivalence Study of Two Different Formulations of Olmesartan Medoxomil After a Single Oral Dose Administration Under Fasting Conditions.

    Not yet reported Pharmtechnology LLC 32 participants Est. completion 2019-06-16 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT03954444

    A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

    Not yet reported Actavis Inc. 1105 participants Est. completion 2020-02-27 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT03956134

    Pharmacokinetic Characterization of Two Novel CG5503 Tablet Formulations in Healthy Volunteers

    Not yet reported Grünenthal GmbH 10 participants Est. completion 2005-06 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT03963596

    Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Myopia

    Not yet reported The Filatov Institute of Eye Diseases and Tissue Therapy 122 participants Est. completion 2020-12-31 3 sites
    Other conditions: Pathologic Myopia
    View official trial listing →
  • Status unknown NCT NCT03973138

    Visual Outcomes and the Predictive Factors in Chinese Patients With Diabetic Macular Edema Treated With Ranibizumab

    Not yet reported, Not yet reported Sun Yat-sen University 100 participants Est. completion 2020-01-01 1 site Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT03973775

    A Bioequivalence Study With Clinical Endpoints to Evaluate the Safety and Therapeutic Equivalence of Permethrin Cream 5% & Elimite™ in Subjects With Scabies

    Not yet reported Saptalis Pharmaceuticals LLC 126 participants Est. completion 2018-12-06 5 sites Stand-alone
    Other conditions: Scabies
    View official trial listing →
  • Completed NCT NCT04015050

    Randomised, Controlled Study to Assess Safety and Tolerance of Infant Formula With Prebiotics and Postbiotics in Healthy Infants.

    Not yet reported Nutricia Research 279 participants Est. completion 2021-12-03 1 site Stand-alone
    Other conditions: Healthy Term Infants
    View official trial listing →
  • Completed NCT NCT04015232

    Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.

    Not yet reported Intas Pharmaceuticals, Ltd. 200 participants Est. completion 2018-06-05 1 site
    Other conditions: Immunogenicity, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT04042454

    To Assess the Safety and Tolerance of Infant Formula With Locust Bean Gum in Infants With Regurgitation

    Not yet reported Nutricia Research 103 participants Est. completion 2023-05-23 16 sites Stand-alone
    Other conditions: Regurgitation, Gastric, Diarrhea
    View official trial listing →
  • Completed NCT NCT04051710

    Clinical Pharmacodynamic Bioequivalence Study of Beclomethasone Dipropionate 40 mcg INH

    Not yet reported Aurobindo Pharma Ltd 1550 participants Est. completion 2019-12-20 1 site Stand-alone
    Other conditions: Bronchial Asthma
    View official trial listing →
  • Status unknown NCT NCT04062370

    Ranibizumab Treatment for Macular Edema Secondary to Retinal Vein Occlusion

    Not yet reported Sun Yat-sen University 100 participants Est. completion 2022-08-31 1 site Stand-alone
    Other conditions: Retinal Vein Occlusion, Treatment, Photocoagulation Burn to Retina, Ranibizumab
    View official trial listing →
  • Completed NCT NCT04087746

    Comparison of Aflibercept Versus Ranibizumab in Management of Diabetic Macular Edema (DME)

    Not yet reported Minia University 400 participants Est. completion 2019-06 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT04123405

    Efficacy and Safety of Acetylcysteine for the Treatment of Acute Uncomplicated Rhinosinusitis

    Not yet reported Sandoz 944 participants Est. completion 2021-04-20 37 sites Stand-alone
    Other conditions: Rhinosinusitis
    View official trial listing →
  • Completed NCT NCT04124094

    A Bioequivalence Study Between Fluticasone and Salmeterol vs. SERETIDE DISKUS® in Healthy Volunteers With Charcoal Blockade

    Not yet reported Respirent Pharmaceuticals Co Ltd. 36 participants Est. completion 2020-06-09 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04147273

    Determination of Postprandial Glycemic Responses by Continuous Glucose Monitoring in a Real-World Setting

    Not yet reported West German Center of Diabetes and Health 12 participants Est. completion 2019-05-31 1 site
    Other conditions: Postprandial Glucose Response, Glycaemic Index, Continous Glucose Measurement
    View official trial listing →
  • Completed NCT NCT04153552

    Upset Stomach Relief for Mild and Moderate Indigestion and Heartburn

    Not yet reported Hawthorne Effect Inc. 161 participants Est. completion 2020-08-18 1 site
    Other conditions: Indigestion, Heartburn
    View official trial listing →
  • Completed NCT NCT04230070

    Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 30 participants Est. completion 2020-11-17 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04230083

    Bioavailability of Dienogest 2.0 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 30 participants Est. completion 2019-12-24 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04231149

    Explorative Clinical Study on the Performance and Acceptance of New Intermittent Catheters in Healthy Volunteers

    Not yet reported Coloplast A/S 9 participants Est. completion 2018-12-20 1 site Stand-alone
    Other conditions: Compliance, Patient
    View official trial listing →
  • Status unknown NCT NCT04245072

    Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

    Not yet reported The Filatov Institute of Eye Diseases and Tissue Therapy 100 participants Est. completion 2022-01-31 3 sites
    Other conditions: Chorioretinitis
    View official trial listing →
  • Completed NCT NCT04276753

    A Randomized, Double-blinded, Placebo Controlled, Monocentric Study to Evaluate the Anti-ageing and Skin Brightening Benefit of the Test Product in Healthy Female Subjects

    Not yet reported Ratan K. Chaudhuri 26 participants Est. completion 2021-04-30 1 site Stand-alone
    Other conditions: Skin Aging
    View official trial listing →
  • Terminated NCT NCT04311489

    Refractory Ascites in Patients With Liver Cirrhosis, and the Potential Treatment With 48 Hours Infusion of Ularitide.

    Not yet reported University of Aarhus 17 participants Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Cirrhosis, Liver, Ascites Hepatic
    View official trial listing →
  • Completed NCT NCT04312334

    Improving the Supertowel: An Alternative Hand Cleaning Product for Emergencies

    Not yet reported London School of Hygiene and Tropical Medicine 32 participants Est. completion 2020-05-30 1 site
    Other conditions: Escherichia Coli Change
    View official trial listing →
  • Completed NCT NCT04317612

    Effect of Nordic Berries on Cognitive Function, Cardiometabolic Risk Markers and Gut Microbiota in Adults With Mild Cognitive Impairment

    Not yet reported Region Skane 96 participants Est. completion 2024-02-01 2 sites
    Other conditions: Cognitive Impairment, Mild, Memory Impairment
    View official trial listing →
  • Completed NCT NCT04332133

    Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

    Not yet reported Minia University 80 participants Est. completion 2019-12
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT04379271

    A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)

    Not yet reported, Not yet reported Immunic AG 234 participants Est. completion 2021-02-23 4 sites
    Other conditions: COVID-19
    View official trial listing →
  • Completed NCT NCT04411940

    Bioequivalence Study of Two Oral Haloperidol Tablets Formulations in Healthy Subjects Under Fasting Conditions

    Not yet reported Cycle Pharmaceuticals Ltd. 32 participants Est. completion 2019-12-18 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04440423

    Bioavailability of Clotiazepam 5 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 26 participants Est. completion 2020-03-28 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04517422

    Efficacy of L. Plantarum and P. Acidilactici in Adults With SARS-CoV-2 and COVID-19

    Not yet reported AB Biotics, SA 300 participants Est. completion 2021-02-02 1 site Stand-alone
    Other conditions: SARS-CoV Infection
    View official trial listing →
  • Status unknown NCT NCT04601675

    Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.

    Not yet reported He Eye Hospital 100 participants Est. completion 2021-09-17 1 site Stand-alone
    Other conditions: Macular Edema
    View official trial listing →
  • Completed NCT NCT04662944

    A Non-interventional Study to Assess the Influence of Automated Optical Coherence Tomography Image Enrichment With Segmentation Information on Disease Activity Assessment in Patients Treated With Licensed Anti- VEGF Injections

    Novartis Pharmaceuticals 494 participants Est. completion 2023-06-28 17 sites
    Other conditions: Neovascular Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT04682873

    A Clinical Study to Assess the Efficacy and Safety of Amizon® Max in the Treatment of Moderate Covid-19, Caused by the SARS-CoV-2 Virus

    Not yet reported Joint Stock Company "Farmak" 592 participants Est. completion 2021-03-26 13 sites
    Other conditions: Covid-19 Disease
    View official trial listing →
  • Completed NCT NCT04705220

    Effect of Nutritional Supplementation With Turmeric on the Cognitive Performance of Subjects With Metabolic Syndrome

    Not yet reported Indena S.p.A 85 participants Est. completion 2025-12-19 1 site Stand-alone
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT04753489

    Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 10 mg in Healthy Male Volunteers in Fasting Conditions

    Not yet reported Pharmtechnology LLC 34 participants Est. completion 2021-03-01 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT04767672

    Study to Assess the Effects of Non Digestible Carbohydrates on Long-Term Glucose Homeostasis in Untreated Prediabetic Subjects

    Not yet reported Tereos 66 participants Est. completion 2024-03 3 sites Stand-alone
    Prediabetes Other conditions: Pre Diabetes, Prediabetic State, Dysglycemia
    View official trial listing →
  • Status unknown NCT NCT04830579

    Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 34 participants Est. completion 2021-04-28 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT04873089

    Efficacy Study of Cosmetic Product RV3278AET0943 Versus Non-treated Group in Adults With Oily and Acne Prone Skin

    Pierre Fabre Dermo Cosmetique 37 participants Est. completion 2018-12-21 1 site
    Other conditions: Acne
    View official trial listing →
  • Completed NCT NCT04878835

    Effects of Ranibizumab in Primary Pterygium Surgery

    Not yet reported Universiti Sains Malaysia 52 participants Est. completion 2020-04-30 1 site Stand-alone
    Other conditions: Patients With Primary Nasal Pterygium
    View official trial listing →
  • Completed NCT NCT04880993

    Bioequivalence of Dapagliflozin 10 mg Tablets Under Fasting Conditions

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 30 participants Est. completion 2021-02-04 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT04883736

    A Study Comparing Tretinoin Gel Microsphere, 0.1% and RETIN-A MICRO ® Gel Microsphere, 0.1% in the Treatment of Acne Vulgaris

    Not yet reported Sun Pharmaceutical Industries, Inc. 973 participants Est. completion 2021-04-16 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Completed NCT NCT04894084

    Investigation of a Supporting Ostomy Product Intended for Leakage Detection

    Not yet reported Coloplast A/S 25 participants Est. completion 2021-07-14 1 site Stand-alone
    Other conditions: Stoma Ileostomy
    View official trial listing →
  • Completed NCT NCT04910399

    Development of an Innovative Health Ingredient From Marine By-products for the Healthy Aging

    Not yet reported Abyss Ingredients 53 participants Est. completion 2023-08-10 2 sites Stand-alone
    Other conditions: Memory Impairment, Age-related Cognitive Decline
    View official trial listing →
  • Completed NCT NCT04926246

    A Study in Healthy Men to Find the Best Formulation of BI 685509 and to Test How it is Taken up in the Body

    Not yet reported Boehringer Ingelheim 39 participants Est. completion 2022-02-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04930042

    Efficacy, Safety, and Immunogenicity of AVT04 With Moderate-to-Severe Chronic Plaque Psoriasis

    Not yet reported Alvotech Swiss AG 581 participants Est. completion 2022-10-11 30 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT04944290

    To Compare the Efficacy and Safety of Perrigo's Product to an FDA Approved Product for the Treatment of Glaucoma or Ocular Hypertension in Both Eyes

    Not yet reported Padagis LLC 447 participants Est. completion 2022-06-21 1 site Stand-alone
    Other conditions: Glaucoma, Open-Angle, Ocular Hypertension
    View official trial listing →
  • Completed NCT NCT04966338

    Efficacy and Safety of Xacrel® (Ocrelizumab) in Participants With Relapsing Remitting Multiple Sclerosis

    Not yet reported Cinnagen 170 participants Est. completion 2021-10-01 15 sites
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT04976088

    Clinical Trial With Diclofenac Sodium Medicated Plaster in Patients With Impact Injuries of the Limbs

    Not yet reported Fidia Farmaceutici s.p.a. 214 participants Est. completion 2018-10-27 16 sites Stand-alone
    Other conditions: Trauma Injury, Inflammation
    View official trial listing →
  • Completed NCT NCT04988178

    Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.

    Brugmann University Hospital 34 participants Est. completion 2021-09-22 1 site
    Other conditions: Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT04991350

    Effect of Ranibizumab Versus Bevacizumab on the Macular Perfusion in Diabetic Macular Edema

    Not yet reported Cairo University 5 participants Est. completion 2022-11-01 1 site
    Other conditions: Diabetic Macular Edema, Macular Ischemia, Diabetic Retinopathy, Vascular Endothelial Growth Factor Overexpression
    View official trial listing →
  • Completed NCT NCT04993222

    A Pilot Bioequivalence Study Between Amphotericin B Liposome for Injection and AmBisome® in Healthy Subjects

    Not yet reported CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 12 participants Est. completion 2020-11-16 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05082376

    Clinical Study to Evaluate the Efficacy of an Over-the-counter (OTC) Sunscreen Lip Balm

    Not yet reported HALEON 38 participants Est. completion 2021-11-11 1 site Stand-alone
    Other conditions: Sunscreening Agents
    View official trial listing →
  • Status unknown NCT NCT05085587

    Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers

    Not yet reported Respirent Pharmaceuticals Co Ltd. 18 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Bioequivalence, Asthma
    View official trial listing →
  • Completed NCT NCT05104931

    PK Evaluation of a Nanoformed Oral IR Piroxicam Tablet in Healthy Subjects

    Not yet reported Nanoform Finland Plc 12 participants Est. completion 2021-02-01 1 site
    Other conditions: Pain
    View official trial listing →
  • Completed NCT NCT05124717

    Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers

    Not yet reported Joint Stock Company "Farmak" 28 participants Est. completion 2019-07-03 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT05125575

    Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers

    Not yet reported Joint Stock Company "Farmak" 28 participants Est. completion 2019-01-19 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Withdrawn NCT NCT05126966

    A Study Of The Effectiveness And Safety Of A 36-Week Refill Regimen For The Port Delivery System With Ranibizumab Vs Aflibercept Treat & Extend In Subjects With Neovascular Age-Related Macular Degeneration

    Not yet reported Hoffmann-La Roche Est. completion 2026-01-30 10 sites Stand-alone
    Other conditions: Neovascular Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT05130411

    An Exploratory Investigation to Identify if Dame Product's "DLM" Works to Improve Sexual Desire and Mood in Females

    Not yet reported Dame Products, Inc. 55 participants Est. completion 2021-12-31 1 site Stand-alone
    Other conditions: Sexual Desire Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT05134441

    Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

    Not yet reported Immunic AG 1121 participants Est. completion 2033-09 91 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Status unknown NCT NCT05138029

    Study on Precision Treatment of Diabetic Retinopathy Macular Edema Guided by Real-time OCT During Operation

    Not yet reported Affiliated Hospital of Nantong University 60 participants Est. completion 2024-05 1 site Stand-alone
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT05151744

    A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema

    Not yet reported Hoffmann-La Roche 187 participants Est. completion 2024-10-01 38 sites Stand-alone
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Completed NCT NCT05179031

    Assessment of the Glycemic Responses to Nutritional Products

    Not yet reported Nutricia Research 13 participants Est. completion 2022-03-11 1 site
    Other conditions: Glycemic Response
    View official trial listing →
  • Withdrawn NCT NCT05182047

    A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study Volunteers

    Not yet reported McNeil AB Est. completion 2022-05-05 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT05201638

    Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis

    Not yet reported Immunic AG 1100 participants Est. completion 2033-10 76 sites
    Other conditions: Multiple Sclerosis, Relapsing-Remitting
    View official trial listing →
  • Completed NCT NCT05212402

    Assessing the Effects of a Cannabidiol Derived From Hemp Supplement in Healthy Adults

    Not yet reported University of South Carolina 56 participants Est. completion 2022-10-30 1 site Stand-alone
    Other conditions: Healthy, Safety Issues
    View official trial listing →
  • Completed NCT NCT05235230

    Partially Replicate Bioequivalence Study of Quetiapine 25 mg in Healthy Volunteers Under Fasting Condition

    Not yet reported Future University in Egypt 32 participants Est. completion 2021-06-03 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05243745

    Exploratory Clinical Study to Investigate the Ability of an Experimental Combination Dentifrice to Protect Sensitive Teeth

    Not yet reported HALEON 120 participants Est. completion 2022-10-03 1 site Stand-alone
    Other conditions: Dentin Sensitivity
    View official trial listing →
  • Status unknown NCT NCT05248334

    A Prospective Study of Ranibizumab in the Treatment of Postoperative Recurrent Vitreous Haemorrhage of Diabetic Retinopathy

    Not yet reported Tianjin Medical University Eye Hospital 120 participants Est. completion 2024-12-30 1 site Stand-alone
    Other conditions: Diabetic Retinopathy, Postoperative Recurrent Vitreous Hemorrhage, Pars Plana Vitrectomy, Ranibizumab
    View official trial listing →
  • Completed NCT NCT05250141

    Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 44 participants Est. completion 2022-02-17 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05282940

    Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 36 participants Est. completion 2022-04-08 1 site Stand-alone
    Other conditions: Therapeutic Equivalency
    View official trial listing →
  • Completed NCT NCT05288075

    Study to Compare Relative Bioavailability of 3 Indacaterol/Glycopyrronium Test Products and Reference Product

    Not yet reported Orion Corporation, Orion Pharma 24 participants Est. completion 2022-06-27 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT05297292

    A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

    Not yet reported, Not yet reported Mabwell (Shanghai) Bioscience Co., Ltd. 433 participants Est. completion 2024-06-30 1 site
    Other conditions: Wet Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT05304949

    Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity

    Novartis Pharmaceuticals 69 participants Est. completion 2025-01-11 6 sites
    Other conditions: Retinopathy of Prematurity
    View official trial listing →
  • Completed NCT NCT05306106

    Glycemic Index of Pastry

    Not yet reported Institut Pasteur de Lille 10 participants Est. completion 2021-07-06 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05322707

    BE Study Budesonide 80 μg and Formoterol Fumarate Dihydrate 4.5 μg Inhalation Product in Asthma Patient

    Not yet reported Cipla Ltd. 1485 participants Est. completion 2023-08-29 1 site
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT05329844

    The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safeyt Profile of Test Product Compared to Reference Product Will be Assessed.

    Not yet reported AET Laboratories Private Limited 66 participants Est. completion 2015-04
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT05340712

    Evaluation of the Efficacy of a New Specific Infant Formula in Case of Functional Constipation

    Not yet reported United Pharmaceuticals 80 participants Est. completion 2024-09 2 sites Stand-alone
    Other conditions: Functional Constipation
    View official trial listing →
  • Completed NCT NCT05383352

    A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas

    Not yet reported Ipsen 177 participants Est. completion 2025-04-15 36 sites Stand-alone
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT05408416

    Comparison of Surgery Outcome Between Preoperative IVR and Intraoperative IVR in PPV for PDR

    Not yet reported Peking University People's Hospital 102 participants Est. completion 2022-05-29 1 site Stand-alone
    Other conditions: Proliferative Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT05413863

    Comparison of the Pharmacokinetic and Pharmacodynamic Properties of Biocon's Insulin R U-500 With Humulin® R U-500 (US Reference Product) in Healthy Subjects

    Not yet reported Biocon Limited 78 participants Est. completion 2022-12-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05436769

    Bioequivalence Study of Klaribact (Clarithromycin) 500 mg, Film Coated Tablet

    Not yet reported University of Karachi 24 participants Est. completion 2012-12-25 1 site
    Other conditions: Healthy Volunteers, Bioequivalence Study
    View official trial listing →
  • Active, not recruiting NCT NCT05461339

    TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration

    Not yet reported BioDlink Biopharm Co., Ltd. 488 participants Est. completion 2025-02 56 sites
    Other conditions: Neovascular Age-related Macular Degeneration
    View official trial listing →
  • Active, not recruiting NCT NCT05476926

    A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products

    Hoffmann-La Roche 6000 participants Est. completion 2027-11-30 299 sites
    Other conditions: Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Branch Retinal Vein Occlusion, Central Retinal Vein Occlusion, Hemi-retinal Vein Occlusion
    View official trial listing →
  • Completed NCT NCT05484388

    Evaluation of Urine Leakage of New Absorbing Incontinence Products in a Home Care Environment

    Not yet reported Essity Hygiene and Health AB 84 participants Est. completion 2023-02-03 1 site
    Other conditions: Urinary Incontinence
    View official trial listing →
  • Completed NCT NCT05506709

    Sterimar Allergic Rhinitis

    Not yet reported Church & Dwight Company, Inc. 59 participants Est. completion 2022-09-21 1 site Stand-alone
    Other conditions: Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT05508074

    Treatment Combining Riluzole and IFB-088 in Bulbar Amyotrophic Lateral Sclerosis (TRIALS Protocol)

    Not yet reported InFlectis BioScience 51 participants Est. completion 2025-01-20 9 sites Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis, ALS
    View official trial listing →
  • Completed NCT NCT05520424

    An Exploratory Investigation of a Supplement to Promote Brain Health

    Not yet reported Parable 40 participants Est. completion 2022-10-30 1 site Stand-alone
    Other conditions: Memory Deficits, Cognitive Change, Stress
    View official trial listing →
  • Completed NCT NCT05532267

    Bioequivalence Study of Ciprofloxacin in Healthy Adult Subjects Under Fasting Condition

    Not yet reported Future University in Egypt 30 participants Est. completion 2020-11-13 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05532332

    Bioequivalence Study of Fluoxetine in Healthy Adult Subjects Under Fasting Condition

    Not yet reported Future University in Egypt 34 participants Est. completion 2021-02-11 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT05533502

    Combination Plant-Based Protein and Marine-Based Multi-Mineral Supplement and Bone Remodeling in Young Adults

    Not yet reported University of Limerick 10 participants Est. completion 2022-10-31 1 site
    Other conditions: Bone Resorption, Bone and Bones
    View official trial listing →
  • Completed NCT NCT05535231

    A Study to Evaluate the Effect of Turmeric in Healthy Participants

    Not yet reported Gaia Herbs Inc. 14 participants Est. completion 2022-10-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05564624

    Effect of Fasting-Mimicking Diet on Skin Health

    Not yet reported L-Nutra Inc 45 participants Est. completion 2022-12-01 1 site Stand-alone
    Other conditions: Skin
    View official trial listing →
  • Completed NCT NCT05576792

    A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

    Novartis Pharmaceuticals 62 participants Est. completion 2024-07-10 1 site
    Other conditions: Retinopathy of Prematurity
    View official trial listing →
  • Withdrawn NCT NCT05609045

    A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster

    Not yet reported Wuhan Rhegen Biotechnology Co., Ltd. Est. completion 2023-12 Stand-alone
    Other conditions: COVID-19 Pandemic
    View official trial listing →
  • Status unknown NCT NCT05642702

    Primary Irritation Patch Test (PIPT) Study Conducted at NovoBliss Research for Shared Panel

    Not yet reported NovoBliss Research Pvt Ltd 26 participants Est. completion 2022-12-20 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05654662

    A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque Removal

    Not yet reported HALEON 197 participants Est. completion 2023-11-30 1 site Stand-alone
    Other conditions: Gingivitis, Dental Plaque
    View official trial listing →
  • Completed NCT NCT05657691

    Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)

    Not yet reported Actinogen Medical 167 participants Est. completion 2024-07-01 12 sites
    Other conditions: Major Depressive Disorder, MDD, Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT05665283

    A Single Dose BE Study of X-396 in Healthy Volunteers Under Fasted Conditions

    Not yet reported Xcovery Holdings, Inc. 32 participants Est. completion 2023-08-08 1 site
    Other conditions: Bioequivalency
    View official trial listing →
  • Completed NCT NCT05678517

    Seven-year Outcomes Following Intensive Anti-VEGF Therapy in Wet AMD

    Semmelweis University 47 participants Est. completion 2022-12-06 2 sites
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT05685277

    Bioequivalence Study of Two Formulations of Tablets Ramipril/Hydrochlorothiazide 10 mg/25 mg in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-07-31 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT05716932

    Focal Laser Single Intravitreal Ranibizumab Retinal Artery Macroaneurysm.

    Dar El Oyoun Hospital 14 participants Est. completion 2023-01-21 1 site
    Other conditions: Retinal Artery Macroaneurysm
    View official trial listing →
  • Completed NCT NCT05786612

    Clinical Performance and Cost Effectiveness of Biatain® Silicone Compared With Standard of Care

    Not yet reported Coloplast A/S 102 participants Est. completion 2023-12-27 9 sites Stand-alone
    Other conditions: Venous Leg Ulcer, Diabetic Foot Ulcer
    View official trial listing →
  • Completed NCT NCT05824195

    Evaluation of Potentially Bioactive Foods With Respect to Cardiometabolic Test Variables

    Not yet reported Lund University 18 participants Est. completion 2023-06-03 1 site Stand-alone
    Other conditions: Healthy Subjects, Diet, Healthy
    View official trial listing →
  • Completed NCT NCT05913921

    Bioequivalence of Amphotericin B Liposome for Injection

    Not yet reported CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 32 participants Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT05940909

    Bioequivalence Study of Perindopril /Amlodipine/Indapamide 8 mg (10 mg)/2.5 mg/10 mg Tablets in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 50 participants Est. completion 2023-11-17 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT05947409

    Single Arm Clinical Trial of Small Molecule Natural Flavonoid Compounds for Intervention in Neurodegenerative Diseases

    Not yet reported Mei Han 30 participants Est. completion 2024-12-31 Stand-alone
    Other conditions: Neurodegenerative Diseases
    View official trial listing →
  • Completed NCT NCT06023082

    A Single-Group Study to Examine the Efficacy of a Gut Health Supplement to Increase Metabolism, Improve Gut Health, and Support Weight Management

    Not yet reported Gut Health, UAB 120 participants Est. completion 2023-11-26 1 site Stand-alone
    Other conditions: Gut Health, Metabolism, Weight Loss, Energy
    View official trial listing →
  • Completed NCT NCT06037590

    A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®

    Not yet reported PureIMS B.V. 26 participants Est. completion 2023-10-27 1 site
    Other conditions: Parkinson, Parkinson Disease, Parkinson's Disease and Parkinsonism
    View official trial listing →
  • Completed NCT NCT06118684

    Clinical Trial to Assess Effect of Verapamil on Systemic Exposure of EP395 and Effect of EP395 on Systemic Exposure of Midazolam and Digoxin

    Not yet reported EpiEndo Pharmaceuticals 37 participants Est. completion 2024-01-02 1 site Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease Exacerbation, COPD
    View official trial listing →
  • Completed NCT NCT06143670

    A Clinical Study Investigating the Effects of a Dentifrice Containing 0.454% Stannous Fluoride on Gingivitis Treatment and Plaque Reduction When Used Twice Daily for 12 Weeks

    Not yet reported HALEON 159 participants Est. completion 2024-03-12 1 site Stand-alone
    Other conditions: Gingivitis
    View official trial listing →
  • Completed NCT NCT06171490

    Pharmacokinetics and Comparative Bioavailability of Nicotine From Two Variants of NP2, NP2-4mg and NP2-6mg, Compared to Nicotine Lozenge 4mg (Loz-4mg) and Nicotine Gum 4mg (Gum-4mg)

    Not yet reported Philip Morris Products S.A. 56 participants Est. completion 2024-03-20 2 sites
    Other conditions: Tobacco Use
    View official trial listing →
  • Completed NCT NCT06176963

    A Study to Evaluate the Usability of the SB11 PFS in Subjects With Wet AMD or Macular Oedema Secondary to RVO

    Not yet reported Samsung Bioepis Co., Ltd. 34 participants Est. completion 2023-12-12 3 sites Stand-alone
    Other conditions: Neovascular Age-related Macular Degeneration, Macular Edema, Retinal Vein Occlusion
    View official trial listing →
  • Status unknown NCT NCT06178640

    Bioequivalence Study of Simvastatin 40 mg Film-coated Tablets in Healthy Thai Volunteers

    Not yet reported International Bio service 46 participants Est. completion 2024-08-24 Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT06193044

    Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

    Not yet reported International Bio service 48 participants Est. completion 2024-07-12 Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT06205979

    Relationship Between Dyslipidemia and The Response of Diabetic Macular Edema to Intravitreal Injection of Anti Vascular Endothelial Growth Factor Agents

    Not yet reported Sohag University 50 participants Est. completion 2024-06-14 1 site
    Other conditions: Diabetic Macular Edema
    View official trial listing →
  • Status unknown NCT NCT06213610

    Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions

    Not yet reported Pharmtechnology LLC 50 participants Est. completion 2024-06-01 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT06215534

    Glin3: Assessment of the Glycemic Responses to Nutritional Products

    Not yet reported Nutricia Research 12 participants Est. completion 2024-06-12 1 site
    Other conditions: Glycemic Response
    View official trial listing →
  • Status unknown NCT NCT06228443

    Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Conditions

    Not yet reported International Bio service 48 participants Est. completion 2024-04-26
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT06232239

    Empagliflozin 10 mg Tablets Relative to Jardiance 10 mg

    Not yet reported Bio-innova Co., Ltd 26 participants Est. completion 2024-04-19 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06233071

    Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

    Not yet reported Bio-innova Co., Ltd 32 participants Est. completion 2024-05-02 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06233266

    Ticagrelor Tablets 90 mg Relative to Originator Ticagrelor Tablets 90 mg

    Not yet reported Bio-innova Co., Ltd 36 participants Est. completion 2024-08-02 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT06237686

    Clinical Investigation Exploring Two Ostomy Product Prototypes

    Not yet reported Coloplast A/S 11 participants Est. completion 2024-02-02 1 site Stand-alone
    Other conditions: Stoma Ileostomy
    View official trial listing →
  • Status unknown NCT NCT06243809

    The Bioequivalence Study of Linagliptin 5 mg Film-coated Tablet in Healthy Thai Volunteers

    Not yet reported International Bio service 48 participants Est. completion 2024-07-02 Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT06244407

    The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions

    Not yet reported International Bio service 40 participants Est. completion 2024-06-02 Stand-alone
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Status unknown NCT NCT06248801

    Vildagliptin and Metformin Tablets 50/1000 mg Relative to GALVUS MET (50mg/1000 mg) Tablets

    Not yet reported Bio-innova Co., Ltd 48 participants Est. completion 2024-10-15 Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Status unknown NCT NCT06267274

    A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

    Not yet reported Amneal Pharmaceuticals, LLC 240 participants Est. completion 2025-05-01 4 sites Stand-alone
    Other conditions: Open-angle Glaucoma, Ocular Hypertension
    View official trial listing →
  • Completed NCT NCT06268847

    Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms

    Not yet reported Abyss Ingredients 92 participants Est. completion 2024-07-03 1 site Stand-alone
    Other conditions: Atopic Dermatitis, Eczema
    View official trial listing →
  • Completed NCT NCT06271993

    SPT for Sensitization of Collagen Dressing

    Not yet reported Covalon Technologies Inc. 27 participants Est. completion 2024-02-16 1 site
    Other conditions: Allergy Skin, Allergic Skin Reaction
    View official trial listing →
  • Status unknown NCT NCT06297174

    Bioequivalence Study of Generic Racecadotril 100 mg Capsules Under Fasting Conditions

    Not yet reported Pharma Nueva 44 participants Est. completion 2024-09-20
    Other conditions: Healthy Vollunteer
    View official trial listing →
  • Completed NCT NCT06300905

    Clinical Study on Malodor

    Not yet reported Colgate Palmolive 100 participants Est. completion 2023-07-02 1 site Stand-alone
    Other conditions: Oral Malodor
    View official trial listing →
  • Completed NCT NCT06305416

    A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

    Not yet reported Incepta Pharmaceuticals Ltd 70 participants Est. completion 2026-05-17 1 site Stand-alone
    Other conditions: Diabetic Macular Edema, Diabetic Retinopathy, Macular Edema, Macular Degeneration, Retinal Disease, Retinal Degeneration
    View official trial listing →
  • Status unknown NCT NCT06308068

    Bioequivalence Study of Diacerein 50 mg Capsule in Healthy Thai Volunteers

    Not yet reported International Bio service 30 participants Est. completion 2024-08-18
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT06326697

    Bioequivalence of Azacitidine 300 mg Film-Coated Tablets in Adult Patients With Acute Myeloid Leukaemia (AML)

    Not yet reported Hikma Pharmaceuticals LLC 32 participants Est. completion 2025-08-28 1 site Stand-alone
    Other conditions: Acute Myeloid Leukaemia
    View official trial listing →
  • Completed NCT NCT06331715

    Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg

    Not yet reported Megalabs 24 participants Est. completion 2024-05-31 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Terminated NCT NCT06446063

    Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.

    Pierre Fabre Dermo Cosmetique 19 participants Est. completion 2025-10-31 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT06481215

    A Safety and Pharmacokinetics Study of Ustekinumab Biosimilar GNR-068 and Stelara® in Healthy Volunteers

    Not yet reported AO GENERIUM 122 participants Est. completion 2022-12-20 2 sites
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT06489418

    A Clinical Study to Assess the Safety and Effectiveness of Test Product in Healthy Adult Human Subjects With Dry and Sensitive Skin.

    Not yet reported NovoBliss Research Pvt Ltd 27 participants Est. completion 2024-08-29 1 site Stand-alone
    Other conditions: Dry Skin, Sensitive Skin
    View official trial listing →
  • Completed NCT NCT06505694

    A Clinical Trial to Assess the Impact of an Alcohol Alternative Herbal Tincture on Signs of Stress Anxiety and Sleep Quality.

    Not yet reported Apothekary 80 participants Est. completion 2024-08-20 1 site Stand-alone
    Other conditions: Anxiety, Stress
    View official trial listing →
  • Completed NCT NCT06569381

    Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets in Healthy Subjects Under Fasting and Fed Conditions

    Not yet reported Overseas Pharmaceuticals, Ltd. 18 participants Est. completion 2024-12-08 1 site Stand-alone
    Other conditions: Idiopathic Pulmonary Fibrosis
    View official trial listing →
  • Completed NCT NCT06595121

    Bioequivalence of IMP 08P1707F0 Relative to Pulmicort® (1.0 Mg/2 Ml Suspension)

    Not yet reported Unither Pharmaceuticals, France 24 participants Est. completion 2024-09-16 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06597084

    Anti-epileptogenic Effects of Eslicarbazepine Acetate

    Not yet reported Bial - Portela C S.A. 129 participants Est. completion 2023-09-11 22 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT06665126

    A Study to Evaluate the Effects of a Prebiotic and Probiotic Supplement to Provide Relief From Symptoms Associated With Bacterial Vaginosis and Yeast Infections.

    Not yet reported Happy V 120 participants Est. completion 2025-03-03 1 site Stand-alone
    Other conditions: Bacterial Vaginosis, Yeast Infection
    View official trial listing →
  • Completed NCT NCT06673654

    A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.

    Not yet reported Sun Pharmaceutical Industries, Inc. 476 participants Est. completion 2024-09-23 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT06674486

    Bioequivalence Study of Iron Sucrose Injection in Healthy Participants

    Not yet reported Sichuan Huiyu Pharmaceutical Co., Ltd 48 participants Est. completion 2025-03-14 1 site Stand-alone
    Other conditions: Bioequivalency, Safety Issues
    View official trial listing →
  • Completed NCT NCT06691386

    Nicotine Pharmacokinetics and Subjective Effects of Oral Nicotine Products Relative to Smokeless Tobacco in Adult Users

    Not yet reported Altria Client Services LLC 64 participants Est. completion 2024-02-08 2 sites Stand-alone
    Other conditions: Tobacco Use
    View official trial listing →
  • Completed NCT NCT06718959

    Efficacy and Safety Evaluation of Jet Floss EX After 8-week Application

    Not yet reported Guang Dong Bixdo Health Technology Co.,Ltd 72 participants Est. completion 2024-06-17 1 site Stand-alone
    Other conditions: Bleeding on Probing, Plaque, Gingival Index
    View official trial listing →
  • Completed NCT NCT06729073

    Comparison of Diclofenac Systemic Exposure From Two Different Products (AMZ001 and Diclofenac Diethylammonium 1.16% Gel) in Healthy Participants After Repeated Topical Administrations for 7 Days.

    Not yet reported Amzell 34 participants Est. completion 2025-07-15 1 site
    Other conditions: Healthy Volunteer
    View official trial listing →
  • Completed NCT NCT06742957

    Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis

    Not yet reported Teva Pharmaceuticals USA 560 participants Est. completion 2025-11-12 26 sites
    Other conditions: Plaque Type Psorisis
    View official trial listing →
  • Completed NCT NCT06797349

    Glin4: Assessment of the Glycemic Responses to Nutritional Products

    Not yet reported Nutricia Research 12 participants Est. completion 2025-03-04 1 site
    Other conditions: Glycemic Response
    View official trial listing →
  • Completed NCT NCT06799364

    Fermented Dairy Product and Bifidobacterium Diversity (ThreeBees)

    Not yet reported Danone Global Research & Innovation Center 182 participants Est. completion 2026-04-15 3 sites Stand-alone
    Other conditions: A03 - Digestive System, B03 - Bacteria
    View official trial listing →
  • Completed NCT NCT06890715

    Comparative Pharmacokinetic Study of Ramelteon Modified-Release Tablets and Ramelteon Tablets in Healthy Subjects

    Not yet reported Overseas Pharmaceuticals, Ltd. 12 participants Est. completion 2024-07-08 1 site Stand-alone
    Other conditions: Chronic Insomnia Characterized
    View official trial listing →
  • Completed NCT NCT06895993

    Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants

    Not yet reported Sichuan Huiyu Pharmaceutical Co., Ltd 84 participants Est. completion 2025-05-08 1 site Stand-alone
    Other conditions: Healthy Adult
    View official trial listing →
  • Completed NCT NCT06942403

    In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation Procedures, After re Epidermization

    Not yet reported Pierre Fabre Dermo Cosmetique 66 participants Est. completion 2024-03-26 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06961019

    Clinical Study to Assess the Safety, Efficacy and In-Use Tolerability of Herbal-Based Sugar Support Effervescent Tablets in Type-2 Diabetes Mellitus Patients

    Not yet reported NovoBliss Research Pvt Ltd 14 participants Est. completion 2026-03-14 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07025980

    Effect of Sinbiotic With Multispecies Probiotics on Liver Parameters Liver Enzymes, Ultrasound, Elastography and Adipokines in Same Cases) in Patients With Metabolic Associated Steatotic Liver Disease.

    Not yet reported Eva Cubric 114 participants Est. completion 2029-07-31 1 site Stand-alone
    MASHMASLD Other conditions: Diabetes Mellitus, Hypertension, Hyperlipidaemia
    View official trial listing →
  • Completed NCT NCT07109453

    To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects

    Not yet reported NovoBliss Research Pvt Ltd 26 participants Est. completion 2025-09-03 1 site
    Other conditions: Normal, Sensitive Skin
    View official trial listing →
  • Completed NCT NCT07121868

    Bioequivalence Assessment Between Two Cariprazine Hard Capsule Formulations

    Not yet reported Aya Mohammed Abdel Magid Abdel Hamid 29 participants Est. completion 2025-01-23 1 site
    Other conditions: Bioequivalence Study in Healthy Subjects
    View official trial listing →
  • Enrolling by invitation NCT NCT07136766

    An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product

    Not yet reported Good Molecules, LLC 40 participants Est. completion 2026-02-16 1 site Stand-alone
    Other conditions: Hyperpigmentation
    View official trial listing →
  • Not yet recruiting NCT NCT07195851

    Dermatological Safety and Skin Compatibility Evaluation of Test Products

    Not yet reported NovoBliss Research Pvt Ltd 26 participants Est. completion 2025-10
    Other conditions: Healthy Subjects
    View official trial listing →
  • Not yet recruiting NCT NCT07200167

    Study of the Efficacy of Dietary Supplementation in Targeting Sleep Quality (NutriSom-01B)

    Not yet reported Institute of Nutrition, Slovenia (Nutris) 70 participants Est. completion 2026-10-30 1 site Stand-alone
    Other conditions: Sleep Onset Latency, Sleep Quality
    View official trial listing →
  • Active, not recruiting NCT NCT07254325

    Pharmacokinetic, Safety and Immunogenicity Study of New Process CMAB015 and Cosentyx in Healthy Volunteers

    Not yet reported Taizhou Mabtech Pharmaceutical Co.,Ltd 114 participants Est. completion 2026-06-01 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT07266779

    Bioequivalence Study of Test Product (T) of Ertugliflozin/Metformin 7.5 mg/ 1000 mg Film Coated Tablets and Reference Product (R) of Segluromet 7.5 mg/ 1000 mg Film Coated Tablets in Healthy, Adult, Human Subjects Under Fed Condition.

    Not yet reported Humanis Saglık Anonim Sirketi 36 participants Est. completion 2025-10-11 1 site
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07269769

    A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

    Not yet reported Tasly Pharmaceutical Group Co., Ltd 450 participants Est. completion 2031-12-31 1 site Stand-alone
    Other conditions: AMD
    View official trial listing →
  • Not yet recruiting NCT NCT07282496

    Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial

    Not yet reported Chung Shan Medical University 115 participants Est. completion 2026-10-31 1 site Stand-alone
    Other conditions: Resistant Starch, Tapioca Starch, Prebiotic Fiber, Blood Sugar
    View official trial listing →
  • Completed NCT NCT07300436

    A Study of TJ101 Injection Before and After CMC Change Following Subcutaneous Injection in Healthy Adult Male Subjects in China

    Not yet reported TJ Biopharma Co., Ltd. 96 participants Est. completion 2026-03-16 1 site Stand-alone
    Other conditions: Healthy Adult Males in China
    View official trial listing →
  • Not yet recruiting NCT NCT07341178

    Acute Effects on Stem Cell Surveillance

    Not yet reported Natural Immune Systems Inc 48 participants Est. completion 2027-03 1 site Stand-alone
    Other conditions: Stem Cell Surveillance
    View official trial listing →
  • Completed NCT NCT07389577

    A Study to Compare JL14002 to Lucentis® in Subjects With Wet Age-related Macular Degeneration (wAMD)

    Not yet reported Jecho Biopharmaceuticals Co., Ltd. 443 participants Est. completion 2024-09-23 1 site
    Other conditions: Wet Age-related Macular Degeneration
    View official trial listing →
  • Active, not recruiting NCT NCT07452692

    A Study to Assess the Skin Irritation and Sensitization of Selegiline TDS in Healthy Subjects

    Not yet reported Corium Innovations, Inc. 232 participants Est. completion 2026-10-13 3 sites
    Other conditions: Major Depressive Disorder (MDD)
    View official trial listing →
  • Completed NCT NCT07466667

    To Determine the Effect of Phaseolean on Glycemic Response to Carbohydrate Rich Meal in Healthy Adult Human Participants

    Not yet reported NovoBliss Research Pvt Ltd 12 participants Est. completion 2026-04-29 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT07469228

    A Study Comparing Tretinoin Gel Microsphere, 0.04% and RETIN-A MICRO ® Gel Microsphere, 0.04% in the Treatment of Acne Vulgaris

    Not yet reported Sun Pharmaceutical Industries, Inc. 1043 participants Est. completion 2025-12-15 1 site
    Other conditions: Acne Vulgaris
    View official trial listing →
  • Active, not recruiting NCT NCT07476144

    Nicotine Pouch Pharmacokinetics Abuse Liability

    Not yet reported JT International SA 55 participants Est. completion 2026-10 2 sites Stand-alone
    Other conditions: Smoking Behaviors
    View official trial listing →
  • Completed NCT NCT07546214

    A Study Comparing Tapinarof Cream 1% and Vtama® Cream 1% in the Treatment of Plaque Psoriasis.

    Not yet reported Sun Pharmaceutical Industries, Inc. 575 participants Est. completion 2026-03-18 1 site
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Not yet recruiting NCT NCT07547384

    Steady-state Bioequivalence Study of Aripiprazole for Injection in Patients With Schizophrenia.

    Not yet reported CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 116 participants Est. completion 2027-11-05 Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT07550504

    A Study to Evaluate the Usability of the SB11 PFS in Trial Participants With Wet AMD, Macular Oedema Secondary to RVO, or mCNV

    Not yet reported Samsung Bioepis Co., Ltd. 30 participants Est. completion 2026-04-09 2 sites Stand-alone
    Other conditions: Age-Related Macular Degeneration, Branch Retinal Vein Occlusion With Macular Edema, Central Retinal Vein Occlusion With Macular Edema, Myopic Choroidal Neovascularization
    View official trial listing →
  • Not yet recruiting NCT NCT07643532

    A Single-center, Randomized, Double-blind, Placebo-controlled, Intervention Clinical Trial to Evaluate the Efficacy and Safety of "KoreaGinseng F Max" on Blood Circulation Improvement in Adults With Poor Peripheral Blood Flow

    Not yet reported Haiphong University of Medicine and Pharmacy 100 participants Est. completion 2028-06-10 1 site
    Other conditions: Blood Circulation, Peripheral Blood Flow, Platelet Aggregation
    View official trial listing →
  • Not yet recruiting NCT NCT07729098

    Intra-Arterial Bevacizumab as an Adjunct to Middle Meningeal Artery Embolization for Chronic Subdural Hematoma

    Not yet reported Dheeraj Gandhi 18 participants Est. completion 2029-06-01 Stand-alone
    Other conditions: Chronic Subdural Hematoma
    View official trial listing →
  • Active, not recruiting NCT NCT07785869

    Effects of a Topical Serum Solution on Hair Characteristics

    Not yet reported Pacagen, Inc. 190 participants Est. completion 2026-09-25 3 sites Added to GLP-1
    Other conditions: Hair Characteristics
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Ranibizumab, NUFYMCO, CIMERLI, Byooviz, Susvimo, LUCENTIS, Ranibizumab 10mg/ml Injection, Test Product, Reference Product

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.